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SUMMARY 
Lymphedema is one of most feared side effects of cancer treatments in the United 
States. This disease leads to swelling of the affected limb and is associated with physical 
and psychological distress. Disease onset has no clear timeline. At risk patients may 
develop lymphedema immediately post-treatment or they may wait decades before 
developing lymphedema. Current medical care for at risk patients does not provide the 
continuous surveillance necessary for early lymphedema detection. Therefore, more often 
than not, patients diagnosed with lymphedema are subjected to a lifetime of maintenance, 
costing thousands of dollars per year in clinical visits and compression garments. In this 
dissertation, implementation of infrared sensor systems was explored and evaluated against 
the standard volume measurement tools used in specialized lymphedema clinics. The 
infrared sensor with the LymphaTech software resulted in good correlation and agreement 
with current measurement tools while being easier to use and more cost-effective than 
commercially available systems. Additionally, the efficacy of utilizing local arm 
geometries for the detection of arm lymphedema was determined. Anthropometric based 
features were extracted from a 3D point cloud using custom code and applied to train 
classification models for lymphedema. These features were shown to detect subtle changes 
in the arm of lymphedema patients with a sensitivity of 61% compared to the current 
standard volume difference measurement, which has a sensitivity of 33.3%. Clinics not 
equipped to detect lymphedema could integrate this infrared system and model as a 
screening tool to improve referral rates to lymphedema clinics.  
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CHAPTER 1. OVERVIEW AND SPECIFIC AIMS 
1.1 Overview 
Lymphedema is considered the most feared side effect of cancer treatment for 
survivors in the United States. Survivors are at a lifetime risk of developing this condition, 
and those who develop lymphedema will likely live with this condition for the rest of their 
life. Despite the pervasiveness of lymphedema among the survivor population, little is 
known about what triggers lymphedema.  
The clinical community has developed protocols to detect lymphedema using basic 
technology and to treat affected survivors. Methods of detecting lymphedema are 
cumbersome and typically require significant training or financial resources. Therefore, 
prospective surveillance models, where at risk patients are consistently monitored for signs 
of lymphedema, are absent in the clinics despite several studies having shown the efficacy 
and long-term benefits of model implementation. It was found that earlier detection of 
lymphedema can reduce the extent of maintenance of this disease, but between the lack of 
continuous monitoring of at risk patients and current detection methods detecting the 
disease too late in its progression, there is a need for a tool that can begin to close this gap. 
Continuing with current approaches, the majority of those who develop lymphedema are 
rendered to a lifetime maintenance of this disease.  
 The challenge in lymphedema detection is two-fold. First, current measurement 
methods are either time intensive or expensive. Thus, there is a need for a new 
measurement method that requires less time to perform and is less expensive to implement 
in clinics specialized in lymphedema. Secondly, there is a lack of prospective surveillance 
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for patients at risk for lymphedema. Therefore, there is a need for a system that can easily 
monitor patients at risk for lymphedema that does not require a specialist and is financially 
affordable for clinics. New methods of detecting lymphedema that do not require 
specialized training and new approaches that have the potential to identify lymphedema 
earlier would address these challenges.  
1.2 Specific Aims 
I will explore the implementation of novel technologies in clinics that are not 
specialized to detect lymphedema and new metrics to diagnose lymphedema. The objective 
is to identify areas of improvement for lymphedema detection to potentially reduce the 
burden of this disease. 
1.2.1 Specific Aim 1: Evaluate the implementation of infrared sensors in clinical settings 
of patients at risk for and with lymphedema. 
This aim explores the efficacy and implementation of an infrared scanning system 
designed previously in the lab in three different clinical environments. 
(a) The infrared system was compared to the breast cancer rehabilitation clinic’s gold 
standard, another optoelectrical scanner, the Perometer. The participants were 
composed of breast cancer survivors with and without lymphedema (LE) in the 
arm.  
(b) The infrared system was tested in a suburban hospital to gather longitudinal 
measurements of breast cancer patients pre- and post-operatively with no known 
lymphedema prior to participating in the study. This clinic does not routinely collect 
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volume measurements, but the tape measure circumferential method was used to 
collect measurements in parallel as a comparison.  
(c) The infrared system was implemented and compared the standard volume 
measurement method used at a general rehabilitation clinic that also specializes in 
lymphedema care. The standard measurement method is the tape measure 
circumference method. Patients with leg lymphedema were measured 
longitudinally with both methods.  
1.2.2 Specific Aim 2: Determine the efficacy of utilizing local geometrically relevant 
anthropometric measurements for the detection of arm lymphedema rather than 
current global volume measurements to detect lymphedema 
In this aim, (a) I gathered arm scans of breast cancer survivors with and without 
lymphedema with a newer iteration of an infrared scanner. (b) Image processing methods 
were developed to analyze the point clouds generated from these scans, and local 
geometrical features were extracted from the scans. (c) These features were then used to 
develop a model to classify lymphedema.  
1.3 Outline 
This work focuses on the implementation of an infrared sensor system in clinics for 
arm and leg lymphedema and its ability to classify lymphedema. CHAPTER 2 provides an 
overview of the lymphatic system and lymphedema, a disease characterized by lymphatic 
system dysfunction. Clinical causes of lymphedema and current treatments for this disease 
were discussed. A thorough review of how lymphedema is currently detected is provided, 
in addition to a review of up-and-coming technologies with promising results found in 
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literature. The implementation of an infrared sensor system, previously developed in the 
lab, was explored in three different clinical contexts in CHAPTER 3. These studies showed 
the system’s efficacy in arm and legs in various clinical contexts. In CHAPTER 4, the 
processing techniques implemented on point clouds collected with the second iteration of 
the infrared sensor system were discussed. The local anthropometric features were 
described and were examined in their ability to train a model to classify arm lymphedema. 




CHAPTER 2. BACKGROUND AND SIGNIFICANCE 
2.1 Lymphatics System 
The lymphatic system is composed of a network of vessels and lymph nodes that 
present throughout the tissues of the body. It serves three primary roles: (1) maintaining 
fluid balance, (2) trafficking immune cells, and (3) aiding in lipid absorption.1–3 Fluid that 
filters out of the vascular capillaries and does not get reabsorbed is transported through the 
lymphatic network, outlined in green in Figure 1, back to the vascular system; this volume 
is approximate 10% of the total fluid volume filtered by the capillaries.  
 
Figure 1 The Lymphatic System represented by the green lines runs throughout the body 
(Royalty free image from ID 36217306 © Shubhangi Kene | Dreamstime.com) 
 Unlike the vascular system, the lymphatic system does not have a central pump like 
the heart. There are intrinsic (lymphatic vessel pumping) and extrinsic (interstitial fluid 
pressure) factors that propel fluid from the extremities back to the subclavian veins.4 Fluid 
in the interstitial space is drained through the lymphatic capillaries, which are composed 
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of blunt-end collections of lymphatic endothelial cells and basement membrane. These 
initial lymphatics join to form collecting vessels, composed of an inner layer of lymphatic 
endothelial cells surrounded by an outer layer of lymphatic smooth muscle cells. Collecting 
vessels are comprised of serial units of lymphangions, segmented by bileaflet valves. These 
units pump to propel fluid unidirectionally back towards the vascular system. 
 When the lymphatic system does not operate properly, a variety of complications 
can occur. Dysfunction has been implicated in cardiovascular disease, cancer metastasis, 
obesity, and infection, but the specific mechanisms are not yet known.5 When the 
lymphatics is unable to properly remove the protein rich fluid, fluid accumulation occurs, 
which can lead to lymphedema.  
2.2 Lymphedema 
2.2.1 Definition, Types, and Causes of Lymphedema 
Lymphedema (LE) is a condition that is the result of an imbalance between the 
vascular capillary exchange and lymph drainage.6  Lymphedema can be defined as an 
abnormal accumulation of protein rich fluid built up in the superficial tissue.7 This 
insufficiency can be a result of (1) the influx of fluid either due to higher rates of capillary 
filtration or lower rates of reabsorption or (2) the reduction of drainage in the lymphatic 
capillaries. While the specific mechanism that results in LE is unknown, there are long-
term impacts on those who develop this disease. The physical manifestation of 
lymphedema is characterized by the swelling of the affected limb as a result of fluid 
buildup. Over time, this accumulation of protein rich fluid leads to fibrosis and lipid 
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deposits. While this disease is commonly not fatal, the morbidity severely impacts the 
quality of life (QOL) of those affected.8–10 
There are two types of lymphedema, primary and secondary.11 Primary 
lymphedema is when lymphedema is not a direct result of another medical condition, and 
onset can range from birth to adulthood. Congenital lymphedema presents at birth, whereas 
lymphedema praecox occurs between the ages of 1 to 35 years, and lymphedema tarda 
occurs after 35 years. Secondary lymphedema is defined as a result of a medical condition, 
typically due to some occurrence later in life such as cancer treatment or filariasis. In the 
United States, the most common cause of lymphedema is the result of cancer treatment that 
disrupts the lymphatic network. Between radiation and surgical interventions, the survivors 
of cancer are at high risk of developing lymphedema over their lifetime.12 This disease can 
occur at any point post-treatment, at any age, and among any gender and racial background. 
It is important to remember that there are non-cancer related lymphedema, and these cases 
tend to be underreported.13 While there are a multitude of studies that show specific 
activities to be high-risk for development of lymphedema14–18, the mechanisms of the onset 
of lymphedema are unclear.  
In the United States (US), breast cancer (BC) survivors make up a large portion of 
lymphedema cases, and BC is the leading cancer diagnosis among women and was 
expected to account for 30% (or 63,410) of all new cancers in women in 2017.19 
Fortunately, the survival rate has improved over the past couple of decades, but that means 
there are more survivors who are at a lifetime risk of the common complication of BC 
treatment, breast cancer-related lymphedema (BCRL).20 BCRL is a chronic condition that 
begins with few physical manifestations; as it progresses, changes like the swelling of the 
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limb and the pitting and thickening of the skin occur.21 A recent study showed 41.1% of 
survivors had developed BRCL at the 10 year post axillary lymph node dissection (ALND) 
surgery.22 It has been reported that approximately 20-25% of survivors will develop BCRL, 
even when patients were treated with less invasive surgical treatment techniques.20,23,24  
Among the breast cancer survivorship community, lymphedema is considered one 
of the most feared side effects of cancer treatment.25 The mechanisms of what triggers 
lymphedema among these survivorship group is unclear. The timing of onset varies greatly 
among those who develop lymphedema, while a large portion never develops this 
condition. Because of this large window of onset, continuous monitoring of at risk patients 
is critical but is severely lacking in the clinics based on the typical follow-up protocols. A 
decade ago, the cumulative incidence of lymphedema was 42% with 80% occurring in the 
first two years of diagnosis and 89% in 3 years, ranging from mild to severe.26,27 As 
techniques for cancer treatment have become less invasive, risk for lymphedema 
development has been reduce to 25%.20 Even though rates of lymphedema onset has fallen, 
survival rates have increased in a growing cancer population, resulting in an increased 
number of lymphedema cases. Additionally, studies have shown that health-related QOL 
decreases in breast cancer survivors with diagnosed lymphedema.28–30 Another study 
showed the impact lymphedema had psychologically and socially on those who developed 
this condition.31 Therefore, it is important to identify BCRL earlier on, so the disease may 
be successfully managed with minimized impact on QOL.32 
  Several studies have found that cancer and treatment related risk factors are 
connected to lymphedema, especially among the cancer survivorship population. The 
cancer stage is a factor of lymphedema development risk, because it influences the extent 
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of surgery required to remove all of the positive lymph nodes. The more positive lymph 
nodes found in surgery correlated with higher with lymphedema development.33 Type of 
surgical intervention is long seen as an indicator of risk for lymphedema development. 
ALNDs are more extensive, removing 5-30 lymph nodes in the axilla region, and has been 
connected to higher rates of lymphedema development post-treatment, upwards of 56% 
when combined with radiation.12,28,34 Sentinel lymph node biopsies (SLNB) are a less 
invasive surgical technique to remove lymph nodes and has been shown to reduce 
lymphedema incidence rates but may not be an option for more aggressive cancers.20  
Non-treatment related factors have also been connected to the development of 
lymphedema. There have been many tall-tale lifestyle recommendations to minimize risks 
for lymphedema development, such as avoiding air travel, repetitive motion activities, 
extreme temperatures, vigorous exercise, and pressure.35 Infections or injury to the at risk 
limb has been cited to be a factor of lymphedema development.34 Obesity is the most 
commonly noted non-cancer related risk for the development of lymphedema.36–40 
Regardless, these factors are not considered enough to predict lymphedema progression 
among patients, which means detection is reliant on clinician assessment in conjunction to 
patient history.41 
2.2.2 Progression and Classification of Lymphedema 
Lymphedema progression has several stages ranging from subclinical to three (3), 
but these stages are loosely defined in the field. The International Society of Lymphology 
(ISL) uses a three-stage classification that focuses on the physical changes of the limb 
(Figure 2).42 There are no current classifications of lymphedema based on the underlying 
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causes of lymphedema such as adipocyte deposits, lymph flow characteristics, etc. In the 
Stage 0, this disease is reversible, but it is difficult to detect clinically since physical 
changes are modest at best. Lymphatic transport may exhibit insufficiencies, and 
bioimpedance measurements could capture this change. Bioimpedance measures the 
resistance to electrical current to determine the composition within the body, as resistance 
in extracellular fluid is different than that in tissue. As the disease physically manifests in 
swelling, lymphedema is considered to have progressed to Stage I. The fluid is high in 
protein content, and pitting may occur. Stage II lymphedema patients have more 
pronounced swelling, and the condition is no longer reversible. Pitting may subside as 
excess fat deposits occur and fibrosis starts. In Stage III, skin thickening occurs alongside 
further swelling. 
 Lymphedema can also be classified based on severity of volume differences, 
comparing the affected limb to the contralateral limb. The ISL states that minimal severity 
can range from a 5-20% increase; moderate is defined as 20-40% increase; and severe is 
any increases greater than 40%.42 Stillwell developed a classification for lymphedema that 
outlines differences of 0-10% to be insignificant, 11-20% to be slight, 21-40% to be 
moderate, 41-80% to be marked, and greater than 80% to be severe.43 Other clinics consider 
mild swelling to be a 5-10% increase. Moderate swelling would be an 11-15% increase. 
Severe swelling would be an increase greater than 15%.44  Overall, there are a multitude of 
systems to classify lymphedema based on volume differences, making detection difficult 
and inconsistent.  
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Figure 2 Lymphedema Progression for cancer survivors. Non-cancer related lymphedema 
progress similarly but the initial event varies. Courtesy of J. Brandon Dixon and Michael 
Weiler (2015). Images are courtesy of Charles McGarvey and Guenter Klose.  
2.2.3 Treatment of Lymphedema 
It is important to establish that there is no cure for lymphedema. Once progression 
of lymphedema begins, intervention is to stop progression and minimize its impact on the 
patient’s QOL Treatment for lymphedema ranges widely from nothing due to the lack of 
trained therapists to aggressive surgical interventions. 
Treatment of lymphedema typically focuses on changes in the limb volume. The gold 
standard treatment for lymphedema is complete decongestive therapy (CDT). CDT has two 
phases; Phase 1 is the reduction phase, and Phase 2 is the maintenance phase. More 
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specifically, the reduction phase focuses on improving the skin of the affected limb and 
removing the excess fluid built up in the limb through manual lymphatic drainage (MLD). 
MLD is performed by specially trained therapists. For more aggressive reduction of the 
limb affected, pneumatic compression have been used with long-term success at 
maintaining reduced volume.45–48 In the maintenance phase, the patient is placed on a self-
management program that involves wearing compression garments to minimize swelling 
in the limb.  One study showed that the initial fluid volume was the best indicator of the 
success of therapy treatment for lymphedema.49 This finding further reinforces the need 
for prospective surveillance, as therapy can start as soon as swelling can be detected.  
Surgical interventions have been developed to treat lymphedema but are reserved for 
a small number of cases due to its invasiveness and high risk. There are three options: 1) 
debulking procedures to remove subcutaneous tissues, 2) bypass procedures that facilitates 
lymph drainage, and 3) prophylactic surgeries.50 Lymphaticovenular (LV) anastomosis 
creates a bypass for the lymph to drain to the venous system and typically done as a last 
attempt at treating lymphedema but can also be performed prophylactically.51  
While there are treatment options, options are limited and only alleviate some 
symptoms of lymphedema. Therefore, more research about the underlying mechanisms for 
lymphedema is critical to a successful move towards finding a cure. In the meantime, better 
ways to detect lymphedema in order to stop progression can minimize the impact it has on 
patients’ QOL, as advancements in technology allow for new approaches for detection and 
monitoring.  
2.3 Current Clinical Detection of Lymphedema 
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There are a variety of methods and diagnostic criteria for lymphedema detection and 
diagnosis. The National Lymphedema Network outlines various methods of diagnosing LE 
ranging from volumetry to bioimpedance to lymphoscintigraphy to signs and symptoms.52 
2.3.1 Volume Measurements 
 The most common method of detection is assessing and tracking volume of the 
limb of interest. There are many tools to gather volume measurements, but they all have 
clinical barriers (summarized in Table 1). Tape measures are used to gather circumferential 
information at a set serial interval along the limb. These circumferential measurements are 
inputted into a truncated cone formula with either a circular or ellipsoid assumption to 
calculate a volume. The gold standard is using water displacement, where the region of 
interest is submerged in a water-filled container, and the volume of water displaced is 
assumed to equal the volume of the limb submerged. More recently, infrared sensors have 
been implemented in a variety of systems to measure volume.  
 The tool often used in clinics is the tape measure method due to its low financial 
cost. Providers need to invest in training to maintain high intra- and inter-person accuracy 
and precision, and significant amount of time of the patient visit is dedicated to collecting 
this volume information. This tool is relatively easy to keep clean by wiping down the tape 
measure between each patient. Even though this tool is the most common, only clinics that 
specifically conduct surveillance and treat lymphedema implement this procedure into the 
workflow. 
Water displacement is another tool that does not require a large financial 
investment. Water displacement is considered the gold standard for volume measurements 
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with studies showing its high reliability and accuracy.53,54 This method requires the patient 
to position oneself and submerge the limb of interest into a tank of water. The volume of 
water displaced is collected and assumed to be equal to the volume of the limb submerged. 
While it is the gold standard tool, water displacement is also time consuming, and more 
importantly, it places patients with open wounds at risk for infection, which can exacerbate 
lymphedema symptoms. As a result, is not implemented clinically.27,36 
Infrared sensor systems show a lot of promise as the future volume measurement 
tool. Many of these systems show high levels of accuracy and precision, while maintaining 
high levels of hygiene. As with the implementation of technology, some of these systems 
can be complex requiring more significant financial investment that would preclude clinics 
from obtaining those tools. Additionally, the footprint of systems requiring dedicated space 
could also make integration into the clinical workflow difficult.   
Table 1 Volume measurement tools comparison 
Tool Time Tool Cost Hygienic  Training 
Tape Measure High Low Moderate High 
Water Displacement  Moderate Low Low Moderate 




 Clinically, there are a wide variety of diagnostic criteria when measuring limb 
volume. Two protocols are to either assess (1) limb volume or circumference change, 
where the same limb is tracked over time, or (2) limb volume or circumference differences, 
where the limb is compared to the contralateral limb at a specific time point. When 
assessing limb volume, the diagnostic criteria is a volume change greater than 200mL or a 
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percent volume difference greater than 10%. When assessing limb circumference, the 
diagnostic criteria is a circumferential change or difference greater than 2cm. Armer et al 
showed that when comparing four methods of lymphedema criteria (10% change in 
volume, 200mL change in volume, 2cm change in circumference, and signs and 
symptoms), different criteria led to different rates of lymphedema diagnosis ranging from 
21-70%.55 Therefore, the detection of lymphedema is highly variable for clinics that do not 
specialize in lymphedema detection, where the therapist is trained to use multiple inputs to 
detect and diagnose lymphedema.  
2.3.2 Bioimpedance Spectroscopy (BIS) 
Bioimpedance spectroscopy is a method that measures the water content in the 
tissues. This technology is popular among the fitness industry, but over the last couple 
decades, it has been used to assess at risk patients of lymphedema. In this measurement, a 
low frequency electrical current is flowed through the limbs of interest. This current can 
pass through extracellular space fluid but cannot pass through intracellular fluid. The 
impedance or opposition to the current can be measured and be inversely related to the 
amount of fluid in the body. This measurement can identify fluid build-up in subclinical 
lymphedema cases.52 The L-DEX (Impedimed Ltd, Australia) is a product often used in 
studies exploring the use of BIS. The normal range for this device is an L-Dex score 
between -10 to 10 or a change in score greater than 10. More recently, the Inbody 720 was 
explored to determine clinical criteria for lymphedema detection but requires further 
investigation on its ability to predict lymphedema development.56  
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 BIS has been shown to have the ability to identify lymphedema earlier in its 
progression, which could delay disease progression.57,58 Among breast cancer survivors, 
the BIS and Perometer measurements were compared with a sensitivity of 73% and 
specificity of 84% at 6 months post-surgery.59 Despite the promise of this device, there are 
some limitations of using a BIS device for lymphedema assessment. There are few studies 
that report on its accuracy in later stages of lymphedema.52 Detection is currently limited 
to unilateral cases of lymphedema, since the contralateral limb is used as a baseline for 
water volume. This device costs approximately $10,000 with a 5-year lifespan in addition 
to non-reusable electrodes, limiting this method’s usefulness in as clinical surveillance tool. 
Currently, BIS is difficult to implement in the clinics for surveillance of high-risk 
populations. The need for prospective surveillance for populations at risk, who may not 
show symptoms or have complications that would require a clinician, is necessary for the 
effectiveness of lymphedema detection through BIS. 
2.3.3 Lymphoscintigraphy and Near Infrared Imaging 
Lymphoscintigraphy is a method that can image lymphatic vessels and look for 
abnormally functioning lymphatic system. This nuclear imaging technique maps the route 
of injected radio-labelled proteins in the limb being assessed. While lymphoscintigraphy 
cannot differentiate between lymphedema versus other causes of insufficiency, it can 
confirm clinical diagnosis of lymphedema at high levels of sensitivity and specificity.13,52,60 
Therefore, lymphoscintigraphy is the best way to confirm lymphedema, but it would be 
difficult to prospectively surveillance all at risk patients through this method. Such 
specialized imaging is expensive and requires training to properly inject and image.  
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 Near infrared imaging can real-time dynamically visualize how the lymphatic 
vessels are functioning. Similar to lymphoscintigraphy, a dye is injected, and the camera 
can capture where and how the dye moves in the lymphatic vessels. This system is also 
expensive, currently limited to most research clinics, and not widely available for 
prospective surveillance of at risk populations.  
2.3.4 Signs and Symptoms 
The onset of lymphedema has signs and symptoms (S&S) that patients would 
experience. These signs include but are not limited to feeling of heaviness, swelling, skin 
texture changes, reduced mobility, tightness in clothing/jewelry.26,61  
While this subjective approach has been shown to be effective, it heavily relies on 
the patient reporting these signs and symptoms.62 Therefore, patient education on the signs 
and symptoms of lymphedema and patient compliance are critical to successful detection 
of lymphedema.24,63,64 Questionnaires have been developed to help gather this information 
from patients.65–67 Nonetheless, lymphedema diagnosis is not often made solely on these 
questionnaires, and typically require a therapist assessment of the limb. At risk patients 
who are unaware of such side effects post cancer-treatment may not be properly monitored 
for lymphedema onset, and standard supportive care would not recognize lymphedema 
onset until later in its progression when it is no longer reversible. Thus, it is imperative to 
have a more agnostic tool to aid with lymphedema detection.  
2.3.5 Clinical Standards 
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 Lymphedema manifests over a long period of time. This wide range of time for 
onset makes it difficult to detect and diagnose and lymphedema, because the responsibility 
lies on no specific field for a patient. It is hard to say whether the responsibility falls on the 
oncologist on the medical, surgical, or radiological side or on the physical therapist on the 
rehabilitation side. It could even be the patient’s internist’s responsibility. Typically, in the 
field, the physical therapists trained to be aware of lymphedema development have 
diagnosed its onset, which relies on the patient needing physical therapy and visiting often 
enough to detect any changes in the limb over a period of time. Clinically, it is not standard 
protocol to begin measuring every at risk patient at the start of cancer treatment, which 
compounds the difficulty of lymphedema detection. I strongly believe that the success of 
prospective surveillance should ideally fall on the team of physicians that treat the patient 
over the course of cancer care, but the patient’s primary care physician is likely to provide 
the most consistent medical care. Regardless, this task is difficult due to the challenges and 
specialization associated with being able to detect lymphedema with current tools. 
Furthermore, there is a variety of measurement methods and criteria for 
lymphedema detection and diagnosis. Thus, there is no single universal protocol to detect 
and diagnose lymphedema, and as a result, a range of diagnosis occurs depending on the 
method and criteria used.55 Methods that are considered more accurate and consistent can 
be difficult to access and/or implement due to financial or spatial costs for a clinic.  
Therefore, there is a need for a method that combines the accuracy and consistency of the 
clinical standards, while simplifies the measurement acquisition process and is priced 
within most clinical budgets for devices. Lowering these barriers to entry for lymphedema 
monitoring into all clinics can provide the platform for more widespread lymphedema 
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prospective surveillance for at risk patients. This surveillance could improve patient 
referrals to physical therapy and rehabilitation clinics with specialized lymphedema care.  
Currently, technologies to detect and monitor lymphedema have their drawbacks 
and could be the cause for a lack of prospective surveillance. To optimize the detection of 
lymphedema and halt its progression, many studies have shown the need for prospective 
surveillance in order to recognize early signs of lymphedema.17,32,68,69 Binkley et al. 
showed that women find lymphedema more distressing than the cancer itself. Even though 
ongoing prospective surveillance is shown to be necessary for earlier detection, Binkley et 
al. found that few women received the necessary referrals to rehabilitative clinics. Many 
did not have baseline measurements, which complicated the lymphedema detection 
process.69,70 As a result, there are many detection criteria that is capable of detecting 
unilateral lymphedema, but bilateral manifestations of lymphedema are still difficult to 
detect with current standards until significant swelling of the limbs has occurred. 
While tape measure circumference measurements are commonly done, many of 
these are done in physical therapy environments. This method requires significant training 
and certification to perform consistent measurements with low intrapersonal variability. 
Commercially available infrared systems that can measure volume are costly financially 
and spatially, requiring the finances to acquire the device and the dedicate space for the 
measurement device. Other methods like BIS and lymphoscintigraphy are financially 
costly, and therefore are limited to larger hospital settings with the resources available. 
These challenges need to be overcome in order to implement more widespread surveillance 
of lymphedema among at risk populations. Additionally, out of the various methods of 
detection, the more expensive methods are the only ones that can detect bilateral cases of 
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lymphedema (Table 2). For volume measurements to detect lymphedema, prospective 
surveillance is necessary but is currently not a standard.  
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Another important aspect to consider is the factors affecting the adoption of the 
methodology among clinicians. The measurements would need to be easy to use and 
outputs would need to be informative and useful for their patients. Clinics that are currently 
not measuring patients for signs of lymphedema may need to be properly incentivized to 
do so.71 Therefore, there is still a need for more accessible technology that can assess limb 
volume to aid in the detection of lymphedema and alleviate the process of monitoring the 
disease through the duration of therapy.  
2.4 Infrared Sensors for Lymphedema Detection 
With the advancement of technology, infrared sensors are easier and cheaper to 
acquire commercially. As a result, more systems have been developed to simplify the 
volume measurement process. While there have been many infrared systems that have been 
developed, the most popular commercial tool among lymphedema clinics that utilize such 
approaches is the Perometer. 
2.4.1 Perometer 
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A commercially available volume measurement tool is the Perometer (Pero-System 
Messgeräte, Germany), an optoelectronic volumeter that has been shown to be quick and 
reliable.72,73 It is composed of a rectangular frame lined with perpendicular photosensors, 
opposite to light emitting diodes (Figure 3). As the frame moves over the limb being 
measured, two diameters are acquired for each 3.1 mm thick serial segment, and a volume 
can be calculated based on a circular or ellipse cross-section.72  
 
Figure 3 Perometer configuration shows a frame composed of two rows of light 
transmitters and receivers. When panned over the limb of interest (arm or leg), a volume 
can be calculated based on the diameters used to calculate cross-sectional area at specific 
intervals. 
Comparing arm volume of healthy and lymphedema patients from sequential 
circumference method versus the Perometer have demonstrated a correlation of R = 0.985 
(R-squared = 0.970) and R = 0.988 (R-squared = 0.976), respectively.72 In a study 
comparing the Perometer to circumferential measurements with a tape, the Perometer was 
found to be more accurate, resulting in smaller standard errors and narrower confidence 
intervals, and reliable with Cronbach’s alpha > 0.9 for experts.74  
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Despite being expensive, Perometers can be found in numerous European clinics 
due to its consistency and ease of use. Adoption of this method of volume measurement in 
the United States have been slower as a result of its high financial cost and lack of a 
reimbursement strategy through the US healthcare system. Additionally, the Perometer has 
a large spatial footprint, which is an obstacle in clinics where dedicated space for a device 
whose measurements have yet to become a standardized measure or protocol is difficult to 
justify. 
Another similar device is the Volometer®, which has been used in various 
studies.54,75 Studies have shown that optoelectronic volumeters are reliable.76 
Unfortunately, these devices are costly and have seen slow adoption in clinics with many 
opting to continue using tape measure circumferential measurements, despite it being time 
consuming and requiring training. Additionally, these volumeters have a large immobile 
footprint, which can be troublesome to implement in clinics and hospitals where physical 
space is limited.  
2.4.2 Other infrared systems from literature 
There are several papers published in literature using infrared systems to measure 
volume of human limbs. Recently, Moreira et al assessed upper arm volume and motion 
using the Kinect-based system’s depth data and skeleton to develop an evaluation tool for 
upper-limb function. Although arm volume was used to identify patients with reduced arm 
mobility, volume accuracy was not provided.77 Since then, there have been several studies 
that have explored the viability of using these lower cost sensors as a means for limb 
volume assessment. Ohberg et al showed that their three 3D-camera system was 
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comparable to arm volume performance via water displacement (p=0.270) with it over 
estimating by approximately 45.25mL.78 Lu et al developed the Iterative Clustered Closest 
Points (ICCP) algorithm to measure limb volume based on scans taken from a single Kinect 
sensor rotated around a patient, which also included other sensors such as gyroscopes and 
accelerometers.79 Comparing to volumes from water displacement, their system resulted in 
R = 0.98317 (R-squared = 0.9666). Buffa et al validated the used of SkanLab for total arm 
volume estimation with the Kinect sensor on a rotating detection frame that resulted in a 
9.9 mL underestimation compared to water displacement.80  
More recently, Hameeteman et al showed a correlation of R = 0.994 (R-squared = 
0.988) when comparing volume from the 5-pod, 15-camera, 3D stereophotogrammetry 
system to the volume from water displacement.81 Using the same system, Hoevenaren et 
al showed the use of this system in measuring hand lymphedema reliably, while Verhulst 
exhibited the reproducibility of the system’s ability to measure volume in the hand and 
forearm.82,83 Karakashian et al scanned arm lymphedema patients by rotating a 
commercially available camera with color and depth sensors 360 around the arm with high 
repeatability.84 Landau et al showed a strong correlation with water displacement in 3D 
arm measurements (R-squared = 0.990) using the Vectra 3D system.85 While these 
techniques have achieved a high level of accuracy, many of these systems require 
significant financial resources, multiple providers assisting with the measurement, and/or 
substantial physical space due to either a large number of cameras or needing room to rotate 
the sensor around the patient, and it is likely that all of these factors have played some role 
in the lack of wide-spread clinical adoption of these approaches. A summary of these 
methods can be found in Table 3. 
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Furthermore, a comparison between the iSense, Sense, and Artec Eva 3D scanners 
were used to scan leg lymphedema patients.86 Their results showed a correlation of R > 
0.92 (R-squared > 0.85) when compared to water displacement. In a recently published 
study, a 3D infrared depth sensor integrated with a tablet and custom software also 
indicated promising results when measuring filarial leg lymphedema patients.87 The study 
shows a high correlation between LymphaTech device and water displacement (R-squared 
> 0.98).  
Other systems in literature but not on the market (that I am aware of): 












Moreira (2015)77 48 (24) N/A 1 Kinect Stationary 
Ohberg (2014)78 25 (25) 29.2  3 Kinect Stationary 
Lu (2014)79  10 (1) N/A 1 Kinect Rotation 
Buffa (2015)80 30 (0) 23.3  1 Skanlab Rotation 
Hameeteman (2016)81 11 (11) N/A 15 3dMD Stationary 
Hoevenaren (2016)82 18 (18) N/A 15 3dMD Stationary 
Verhulst (2017)83 10 (0) N/A 15 3dMD Stationary 
Karakashian (2017)84 24  N/A 1 Xtion Pro 3D Rotation 
Landau (2018)85 11 (11) 26.2 1 Vectra 3D Stationary 
      BMI, body mass index; LE, lymphedema; N/A, not available. 
  
There are many published systems in literature, but none have reached commercial 
success in the clinics in the US despite great measurement performance. This lack of 
integration into the clinics is likely due to other obstacles posed in the clinical workflow. 
Clinics operate on tight budgets and schedules in already maximized space. Therefore, 
systems that are too expensive, requiring many sensors and/or accessories impose financial 
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strain to obtain and maintain. More complex systems are not only potentially more difficult 
to operate but likely require dedicated spatial footprint that many clinics do not have 
available. With this in mind, it is not surprising that few published systems have found 
their place in clinics in the United States.  
2.4.3 Our system 
In this dissertation, I explore the use of infrared sensors in various clinical settings. 
The lab developed two different generations of a single infrared sensor system and spun 
off as LymphaTech, LLC for continued development and expansion into the clinical space. 
The work in the document assesses the value these infrared sensors bring to the clinics and 
explores other potential metrics to use for the detection and monitoring of lymphedema. 
The first-generation system was composed of a single Microsoft Kinect sensor 
(Kinect for Windows v2, Microsoft, Washington) connected to a compatible Windows 
computer with a USB port (Figure 4). Custom code was interfaced with the sensor to pull 
depth data with a resolution of 640 x 480 pixels to collect scans of patients from the front, 
back, and sides for leg patients. The whole system is small, light (1656 g for the sensor and 
laptop), and portable but required enough space between the patient and the sensor to 
capture enough of the patient for the scan.  
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Figure 4 Kinect IR system setup. The sensor is connected to the computer via a USB 
port; computer captured is the 2015 Dell XPS 13 with the GUI that allows the operator to 
capture the front, back, right, and left side of the patient seen in the background.  
With feedback from the clinics, the second-generation system was composed of a 
single Structure sensor (Occipital, Boulder, CO) mounted on an iPad Mini 2 (Apple Inc., 
Cupertino, CA) with a customized software platform designed for scanning lymphedema 
patients (LymphaTech, Atlanta, GA) (Figure 5). The sensor provides depth data with a 
resolution of 640 x 480 pixels and is precise to half of a millimeter when taken at 40 cm 
away. Custom code interfaces with the sensor to acquire the point cloud of the limb 
scanned. In contrast with the first-generation, a single .OBJ file is outputted for each scan, 
and each scan captures an individual arm resulting in two files per patient for each arm. As 
a result, 3-dimensional scans of the arm are possible and provide higher resolution 
information. This entire system is smaller (200 x 134.7 x 36.5mm), lighter (totalling 426g 
for the sensor and iPad), and more portable as a single combined device than the first 
generation. In addition to ease of movement of the system in a clinical setting, it also 
requires less space to capture arm scans.  
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Figure 5 Structure sensor system set up with the sensor (behind the iPad) connected to the 
iPad through the lightning port. The tablet displays a box to indicate a region of interest 
and the captured information is painted in white as seen in the image. 
This dissertation will explore the implementation of the first generation of the 
device in various clinical settings and will compare it against the clinic’s standard of 
measurement. With the second generation, I will investigate the possibility of using local 
features of arms to delineate healthy and lymphedema arms as opposed to volume, which 
is the current standard for detection.  
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CHAPTER 3. AIM 1 
3.1 Introduction 
Despite the breadth of techniques that can be used to detect and monitor 
lymphedema, the most common technique in the United States is using tape measures and 
collecting circumferential measurements at evenly spaced intervals. Limited infrared 
sensor systems have been implemented in clinics despite their of ease of use, which is likely 
due to unaccounted challenges.  
Accurate volume measurements are critical for adoption in the clinics, but there are 
other factors to consider. The financial cost of the system is important, including not only 
the device but also any associated subscription and training necessary to maintain accuracy. 
The spatial requirement is a limitation as clinics tend to be small and are overcrowded.88 
Therefore, finding a sufficient amount of space to dedicate to lymphedema detection 
equipment can be difficult. 
 While there have been infrared systems that have been shown to be potential 
replacements for the tape measure circumference method for volume measurement, there 
are few reports of these systems used in the clinical environment. Therefore, evaluation of 
its successful implementation in these settings is unknown. Furthermore, the lack of 
widespread integration of these systems into clinics begs the questions of how successful 
these systems are in the clinical spaces and what are the challenges these spaces presenting.  
This chapter navigates three different situations where the Kinect IR system was 
used and compared to the clinic’s best practices for lymphedema detection and monitoring 
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to explore its clinical efficacy. In Objective 1A, I explore the use of the Kinect IR system 
in a breast cancer rehabilitation center among patients with and without lymphedema. This 
location has a Perometer, which has been shown to be highly accurate. In Objective 1B, 
the Kinect IR system is implemented in a breast cancer clinic at a local public hospital of 
Atlanta, GA, where patients are scanned pre- and post-operatively. Typically, no screening 
of lymphedema is performed at this center. Lastly, in Objective 1C, the Kinect IR system 
is integrated into a physical therapy clinic where patients have lower limb lymphedema, 
and the typical measurement performed uses a tape measure to collect circumference 
measurements.  
3.2 Objective 1A: Assessment of arm swelling among breast cancer survivors with 
an infrared system in a specialized breast cancer rehabilitation clinic 
There are many approaches to clinically diagnose and measure BCRL, but the most 
common is using a volumetric measurement.26,89 A common tool to make volumetric 
measurements is with a tape measure, where circumferential measurements are taken along 
the arm at evenly spaced intervals. Using the circumference measurements, a truncated 
cone geometry, circular or elliptical, is assumed for volume calculations. This method is 
the most common method performed in clinics and does not require expensive equipment 
but can be time consuming and requires training to reduce intra-operator variability.90  
The aim of this study is to show that a single stationary Kinect for Windows v2 IR 
sensor, in conjunction with a custom image processing algorithm, is a tool that can be 
implemented in a clinical setting to calculate arm volume among breast cancer survivors 
with the requisite clinical accuracy. This system is easy-to-use, has a small footprint, is 
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non-invasive, is faster than the commonly used circumferential measurements technique, 
and is an inexpensive alternative in terms of time, cost, and space when compared to other 
systems and devices used to detect, measure, and monitor lymphedema. This combination 
of accuracy and small footprint allows for simple implementation in clinical settings, where 




The women in this study previously had breast cancer and underwent treatment. 
These women were referred to TurningPoint Breast Cancer Rehabilitation by their 
physicians for post-treatment rehabilitation and have been undergoing treatment at the 
rehabilitation center for various periods of time when they were recruited for this study 
from the center. Seventy-three (73) women at varying stages post-surgery participated in 
this study, and thirty (30) of these women have been clinically diagnosed with lymphedema 
in the arm between the wrist and shoulder. Diagnosis was determined by a notation of the 
I97.2 code for lymphedema symptoms in the patient’s chart with the exception of 
lymphedema manifesting in the chest and/or hand, which were not included as a 
lymphedema case for this study.  
Women receiving physical therapy treatment at TurningPoint Breast Cancer 
Rehabilitation were recruited for this study by therapists at the center based on the inclusion 
and exclusion criteria. Participants were required to be female breast cancer survivors who 
may have undergone surgery, chemotherapy, and/or radiation. They must be able to stand 
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unassisted for one minute and must possess all four limbs. Women recruited did not need 
to be diagnosed with lymphedema to participate, and they must be 18 years or older. Prior 
to participating in the study, all participants provided a written informed consent. 
3.2.1.2 Measurement Acquisition Procedures 
In a single visit, the patient was measured once with a single Kinect IR sensor 
(Kinect for Windows v2, Microsoft, Washington) and twice with a Perometer in a 
consecutive manner, using a horizontal measurement frame. Women were asked to wear 
taut sleeveless tops with no jewelry on their arms, although rings were permitted since arm 
volumes consisted of measurements from the wrist to the shoulder. 
Measurements taken by the Kinect IR system required the patient to walk to the 
delineated spot marked on the ground (approximately 1.8 m in front of the sensor) with the 
arms held out, parallel to the ground seen in Figure 1. When in the correct position, the 
software program used for acquisition would visually paint the cartooned version of the 
patient blue, indicating that the patient was in the correct position and ready to be scanned. 
The software algorithm required each patient’s limb to be horizontal to the sensor with a 
tolerance of 10 degrees to ensure separation of the arm and the trunk of the body. When in 
an incorrect position, the cartooned patient was painted red and a prompt in the program 
was given to correctly position the patient. The front and back of the patients were scanned 
in this position for approximately 30 seconds to acquire up to 30 frames. Each frame is 
captured and a .PLY is immediately generated in real-time before capturing the next frame. 
The .PLY files are saved to be processed at a later date (Figure 6).  
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Figure 6 Kinect IR System arm scans. The (A) front and the (B) back scans are taken and 
pseudo arm volumes are calculated for the right and left.  
For Perometer measurements, the patient was positioned next to the device with the 
patient’s arm of interest extended straight, resting the finger tips on a support at the end. 
The frame of sensors and receivers on the Perometer was moved forward once and back 
into position once per scan per arm. For each set of scans (of the right and left arms), the 
volume measurements were collected from the Pero-System database. The wrist for each 
of these scans were manually identified to gather arm volume from the wrist to shoulder. 
The user identified the wrist by locating the point just before an increased slope that would 
indicate the start of the carpometacarpal joint that would lead to the thumb. 
Background information regarding patient breast cancer history were taken from 
the patient’s electronic record. A summary of the patient characteristics can be found in 
Table 4.   
Table 4 TurningPoint participant characteristics (n=73) 
Personal data Mean (stdev)  
Age (years) 
BMI (kg/m2) 
















BCRL Number Yes (%) 
Clinical 
10% Volume difference 
     Perometer 
     Kinect 
200mL difference 
     Perometer 








* Average does not include the three patients who were missing BMI information from 
their electronic records. 
 
3.2.1.3 Scan Processing 
Scans, composed of sequential frames, were post-processed by custom algorithms 
written in MATLAB (version R2015b, MathWorks) to calculate the final left and right arm 
volumes. 
For each patient, the front and back scans had to be filtered to remove noisy data 
points in the point cloud of the whole body. To do so, the point cloud was centered at the 
origin by taking the mean location of the data points in the point cloud. Then, the location, 
color, and joints identified using the Kinect sensor and Kinect SDK were extracted. The 
point cloud was filtered using a nearest neighbor algorithm with a distance of 0.015 and 
degree of four; this filter removed the flyaway points that can be seen in the raw point 
clouds.   
Next, the arms were segmented from the rest of the body captured in the scans. The 
shoulder was auto-detected for each frame, and the rest of the arm from the shoulder to 
thumb was segmented, outlined in Figure 7A. The identification of the shoulders in the 
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front and back scans resulted in four segments – front-left, front-right, back-left, and back-
right. For each segment, the upper and lower boundary points of the arms of interest were 
then smoothed twice using a 3-point moving average filter. This step further cleaned noisy 
data points the arm segment of the point cloud. The script then prompted the manual 
identification of the wrist in each of the four arm segments, which determined where the 
arm was truncated for volume analysis. The x-coordinate of the wrist was manually 
identified (seen in Figure 7B) for each of the four segments on the first frame, and these 
coordinates were used for the subsequent frames to process and truncate the arm from the 
shoulder to the wrist.  
 
Figure 7 Kinect IR System Wrist Identification. The arm is isolated and the code prompts 
for the wrist identification during the scan processing process.  
Final left and right arm volumes of each frame were calculated by using the pseudo-
volumes for the front-left, front-right, back-left, and back-right segments. The pseudo-
volumes were calculated using 1cm slices along the arm times the calculated area in the y-
z plane assuming a circular cross-section. Although I analyzed all the frames acquired, it 
was found that ten consecutive frames resulted in a consistent arm volume output per 
patient (data not shown). This amount was determined by calculating (over a range in the 
number of frames) the cumulative volume average, which is the sum of the volume per 
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frame divided by the number of frames considered. Then, I analyzed the change in 
normalized cumulative volume averages by calculating the difference in consecutive 
cumulative volume averages divided by the initial frame of the sequence. The results 
indicated that the volumes stabilized after five consecutive frames. Therefore, I determined 
that ten frames were sufficient for calculating arm volumes. The set of ten consecutive 
frames, for each of the four arm segments, with the smallest standard deviation of the 
angles of the arm (towards the sensor) was used to calculate the pseudo-volumes of the 
front-left, front-right, back-left, and back-right segments. The average of the pseudo-
volumes of the front-left and back-left was calculated for the left arm volume; the same 
process was applied for the right arm volume.  
The volumes from the two Perometer scans were taken after adjusting the arm 
length in both sets of scans to ensure the same regions of the arms were analyzed with the 
exception of fifteen (15) patients who had one Perometer reading due to limitation of time 
or fatigue. An average was calculated from the two Perometer scans when applicable to 
calculate a right and left arm volume for a patient that was used for analysis in this study.  
Arm lengths for a single participant were matched within each modality in addition 
to being matched between modalities in order to fairly draw comparisons between the 
Perometer and Kinect IR system. Normalized arm volumes were calculated by taking the 
arm volume of interest and dividing it by the arm length of that patient, resulting in an arm 
volume/length metric.  
3.2.1.4 Statistical Analysis 
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Linear regression analyses were performed to determine the level of correlation 
between the Perometer and the Kinect IR system. Additionally, to assess the agreement of 
the Perometer and the IR system, a Bland-Altman plot was generated, where the percent 
volume difference and volume differences between the right and left arm from Kinect was 
subtracted from the volume from Perometer. In clinical settings, a threshold of 10% in arm 
volume difference or a 200mL difference would indicate lymphedema. Therefore, using 
the Cohen’s kappa agreement for categorical data, the outcomes for each modality were 
compared using each threshold.91,92 To compare LE and non LE patients, arm LE diagnosis 
was determined from the patient’s charts, and Mann-Whitney tests were performed. Data 
analysis were run using Prism 6 for Windows (version 6.07, GraphPad Software). 
3.2.2 Results 
While the arm lengths were internally matched for both the Perometer and the 
Kinect IR system, an initial comparison between the modalities was performed in which 
the arm length was not fixed between Perometer and Kinect. As expected, the correlation 
of the volumes initially calculated from these two modalities showed weaker correlation, 
with an R-squared = 0.7785 (Figure 8A). In order to remove the effect of differences in 
arm length acquired between the two modalities without having to actually match the 
length of arm acquired between the two methods, the arm volumes were then normalized 
to the arm lengths of the respective scans, which improved the correlation to a value of 
0.8350 (Figure 8B and did not require accurate registration of the defined “wrist to 
shoulder” distances measured between the two parameters. 
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Figure 8 Correlation without matching arm length between modalities 
 When the arm lengths between the two modalities were matched, the correlation in 
arm volume gave an R-squared value of 0.8799 (Figure 9A). Meanwhile, normalizing the 
arm volumes to the now matched arm lengths produced an improvement to from the 
normalization in Figure 8B, but a drop in the R-squared value to 0.8676 (Figure 9B) from 
the matched arm lengths in Figure 9A. As anticipated, the correlation is stronger when 
matching the arm lengths for each modality to compare arm volumes between them, 
however merely normalizing the volume by the arm length works surprisingly well to 
correct for differences between arm lengths without having to match them.  
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Figure 9 Correlation after matching arm lengths 
  The absolute volume agreement analysis resulted in a difference of -117.6 ± 
228.6mL. To determine agreement between more clinically relevant measurements, Figure 
10A compared the percent arm volume differences between the right and left arms 
measured by the Perometer and the Kinect IR system when arm lengths were matched. The 
Bland-Altman analysis resulted in a difference of -0.4657 ± 6.006%, meaning the 
Perometer and the Kinect IR system produced similar percent volume differences. For 
another clinically relevant metric, Figure 10B compares the arm volume difference (right 
arm volume – left arm volume) measured by the Perometer and Kinect IR system. The 
Bland-Altman analysis showed a difference of 6.016 ± 132.7mL, where Perometer and the 
Kinect IR system produced similar volume differences. 
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Figure 10 Bland Altman plots 
To assess the clinical agreement between the two modalities, the Cohen’s kappa 
agreement coefficient was calculated. Cohen’s kappa ranges from 0 to 1, where 0 indicates 
that any agreement is equivalent to chance and 1 indicates perfect agreement.92 Based on a 
diagnosis of 10% arm volume difference, the kappa was 0.2663, which is deemed a “fair 
agreement”. When considering a lymphedema analysis based on 200mL difference 
between left and right arm volumes, the kappa was 0.5475, which is deemed a “moderate 
agreement”. The agreement strength varied with the method of clinical diagnosis, but both 
showed a fair agreement between the two modalities.  
Interestingly, the percent difference in arm volume when comparing the left and 
right arm of a participant between the two modalities showed an R-squared value of 0.5950 
(Figure 11A). When the absolute percent difference data were segmented based on 
Perometer measurements (<5%, 5-10%, >10%) to identify where the lack of variation 
originated, I found that the most variation fell within the first segment, <5% difference. 
The R-squared value for absolute Perometer measurements less than 5% was <0.0001 
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(Figure 12A). The other two segments where the absolute percent difference was 5-10% or 
greater than 10% had R-squared values of 0.6277 (Figure 12B) and 0.7098 (Figure 12C), 
respectively. The volume difference between the left and right arm correlation between the 
Perometer and Kinect IR system resulted in an R-squared value of 0.6732 (Figure 11B).  
 
Figure 11 Percent Volume Difference and Volume Difference Comparison 
 
 
Figure 12 Percent Volume Difference 
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When comparing patients with lymphedema to those without lymphedema, there 
was no significant difference in percent volume differences (p=0.2806), while there was a 
significantly greater volume difference (p=0.0309) between the right and left arm for 
women with lymphedema (Figure 13A-B). For this comparison, percent difference was 
defined as the larger arm volume minus the smaller arm volume divided by the smaller arm 
volume. The volume difference was defined as the larger arm volume minus the smaller 
arm volume. This adjustment in calculation made the analysis comparing those with and 
without lymphedema agnostic to whether the right or left side was larger. 
 
Figure 13 Non-LE vs LE (A) Percent Volume Difference and (B) Volume Difference 
comparison 
 
3.2.3 Discussion and Conclusion 
It has been shown and recommended by an expert panel convened by the American 
Society of Breast Surgeons that taking preoperative measurements has been helpful with 
the diagnosis of lymphedema, yet it is not performed regularly in the clinic.32,44,69,93 More 
often than not, prospective surveillance of those at risk for developing lymphedema is not 
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done. This lack of information is driven in part by the insufficient resources required to 
make meaningful measurements (i.e. properly trained staff with the dedicated time to 
perform tape measurement evaluations or expensive volume acquisition hardware) that 
cause challenges for a clinic to implement the measurement into the work flow. As a result, 
baseline and immediate post-treatment volume measurements are missing. When post-
treatment volumes are necessary and finally taken, there is no frame of reference to 
understand the significance of the measurement. Since these change-over-time 
measurements are rarely available, percent difference and absolute volume difference 
between the affected and contralateral arm are metrics used to assess lymphedema and its 
severity when the patient is referred to a lymphedema clinic. Patients who have had 
ongoing therapy for swelling may be misdiagnosed, as they may not exhibit the physical 
hallmarks of lymphedema. Additionally, patients suffering from bilateral lymphedema 
may not be diagnosed until significant swelling occurs due to the limitations of current 
lymphedema metrics. If a method for volume surveillance before and after treatment can 
easily be integrated to the work flow, then these baseline measurements can be recorded 
and used to monitor for lymphedema onset for everyone at risk.  
Typical tools used to assess arm volume include taking circumferential 
measurements, water displacement, and infrared sensors. This study explored the use of a 
single infrared sensor and processing algorithm to calculate the arm volume. This method 
was shown to be capable of quickly capturing scans that produced accurate arm volumes. 
Compared to other 3D scanner systems, this proposed device had many benefits without 
compromising the accuracy that is necessary for clinical implementation (Figure 9A, 
Figure 11A-B). While there was variation in percent difference between the two modalities, 
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the variation occurs primarily when the percent difference between arms is less than 5%, 
which is a range more prone to errors due to subtle changes in volume. It is unclear whether 
these changes are a result of the Perometer or the Kinect IR system.  
Additionally, the agreement analysis showed that the bias between the Perometer 
and the Kinect IR system was minimal when assessing the percent volume difference and 
volume difference, which are two common measurements for lymphedema (Figure 10). 
This agreement indicated that moving between the two modalities in a clinic would not 
require much of an offset. The system remains a low-cost and small footprint device due 
to a single camera system that interfaces with a basic computer via USB and does not 
require rotation around the patient. The simplicity in the acquisition process means that the 
system could be easily performed in clinics but also in the home of patients as self-
measurements are possible without an additional person. This acquisition setup requires a 
smaller footprint that leads to simplified implementation in the physical space limitations 
of clinical settings, which can help move the field towards taking prospective 
measurements. 
Patients with and without clinically diagnosed lymphedema were compared. The 
lack of difference between the two groups in percent volume (Figure 13A) was likely a 
result of lymphedema patients undergoing therapy, including the wearing of compression 
garments, and thus were actively managing their swelling. However, when the absolute 
volume difference was compared, the two groups were statistically significant. Other 
papers have noted the lack of consistency among metrics used to detect lymphedema, so 
the discrepancy between the two measurements was not surprising.55 In addition, the study 
indicated there were a small number of women who are not clinically diagnosed with 
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lymphedema but have metrics (whether determined by Perometer or the Kinect IR system) 
that exceeded traditional thresholds used for lymphedema diagnosis; these women had 
percent volume differences greater than 10% and volume differences greater than 200mL. 
So, while volume measurements can be helpful as an initial screen, it can be difficult to 
detect lymphedema based solely on a single volume measurement. Therefore, having a 
system that can be easily integrated into a clinical workflow would allow for more 
longitudinal measurements of a patient at risk, including pre-operative baseline 
measurements, providing more information for detection and would provide a platform that 
could refer patients to lymphedema specialists. 
While there are many advantages to the system used in this study, there are a few 
limitations when compared to other systems. The cost of the technology was approximately 
$950 ($150 and $800 for the sensor and computer, respectively), which is cheaper than the 
Perometer but can be reduced by purchasing a more inexpensive computer. Because a 
dedicated laptop is not necessary, the computer can be multi-purposed to meet other 
clinical needs. With that stated, the market price for this system is unknown since the 
analysis software is not included. It is worth noting that the specific Kinect sensor model 
has been discontinued, but there are other viable infrared sensors that can be integrated 
with this system.  
Additionally, this current system cannot calculate volume based on an elliptical 
cross-section, but studies have shown that only under extreme deviations would assuming 
a circular cross section lead to differences greater than 5%.94 Using clinically relevant 
measurements, the agreement analysis (Figure 6A-B) indicates a standard deviation of bias 
smaller than clinical thresholds utilizing percent volume difference and volume difference. 
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Studies have reported a standard deviation of bias up to 4.3% for arm volumes 
(corresponded to 69.4mL) and 345.4 mL for leg volumes when comparing the Perometer 
and sequential circumferential tape measurements.72,95 While the study reported a slightly 
larger standard deviation of bias, this system is considerably more affordable than the 
comparison. Additionally, it is difficult to directly compare the study results with published 
studies since those studies compared the Perometer against tape measure circumference 
measurements while I compared the system to the Perometer. One study even reported that 
experts performing repeated volume Perometer measurements on a healthy volunteer arm 
had a standard error of 38.99mL compared to tape measure standard error of 25.00mL.74 
Based on this study, it is difficult to determine which system contributed to the larger 
standard deviation of bias, but the deviation is comparable to published comparisons.  
Despite the current limitations, the Kinect IR system has many advantages, 
especially for clinical applications. The Kinect IR system was shown to have a good 
correlation and clinical agreement with the Perometer, which was shown to have a high 
correlation with commonly used circumference measurement methods.72 The use of Kinect 
IR system required no physical contact with the patient, which is optimal compared to other 
volumetric tools such as water displacement and circumferential tape measurements. 
Because there is just a single Kinect IR sensor plugged into a laptop, the spatial footprint 
required for this system is smaller than some of the proposed systems that either require 
multiple sensors or enough radial distance for the sensor to be moved around the patient to 
capture the limb of interest. This study was able to implement this system in a rehabilitation 
center to gather scans with minimal impact on the workflow of the center. The Kinect 
system is quicker than taking circumferential measurements with a tape measure. The 
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scanning acquisition takes approximately a minute plus transitioning time to move into 
position for a total of about two minutes. Meanwhile, tape measure circumferential 
measurements have been reported to take 7 minutes87 but can take longer as this method 
was reported as having a “high” operating time.77 The Kinect system takes minutes to 
acquire all the necessary scans at its current development stage and could be reduced once 
the protocol is optimized. This system is a tool that has many advantages that make it a 
great improvement for arm volume measurements in clinical settings by saving time, 
reducing cost, being accurate compared to the Perometer, and providing a stepping stone 
towards a more prospective approach to lymphedema diagnosis.  
The volume measurement tool developed in this study can calculate volume and 
compare percent volume difference and volume difference between arms in a clinical 
setting of patients with or at risk of BCRL. This system is low-cost and highly correlates 
with the previously developed Perometer system. The system with existing Kinect sensors 
or other compatible sensors can be implemented in clinics and be used as a tool to detect 
and monitor lymphedema. In the next steps, immediate analysis of the scans will be 
integrated with the system to allow physicians and therapists to make decisions regarding 
patient care immediately. To further validate the ease of implementation in clinics, 
expanding the number of clinics and operators is needed. For long-term management of 
lymphedema cases, gathering longitudinal data to show changes in arm volume over time 
would show the system’s ability to monitor changes during a patient’s rehabilitation 
journey. 
3.3 Objective 1B: Evaluation of an infrared system to track arm swelling in the 
breast surgical oncology team of a public hospital 
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This study aims to show how a single stationary Kinect IR sensor with a custom 
image processing algorithm can be a tool implemented in a clinical setting to measure 
changes over the course of breast cancer treatment. The implementation of this system in 
a public hospital of a major city provided feedback about challenges unique to a fast-pace 
clinical setting among a patient group who has just begun their cancer treatment journey 
and are therefore less concerned about the side-effects of their treatment and more worried 
about the cancer itself. This inexpensive alternative system is reasonably priced but also 
reduces the amount of measurement time, decreases the associated training needed, and 
has a small physical system footprint in the clinical space. 
3.3.1 Methods 
3.3.1.1 Participants 
All participants in this study had been diagnosed with breast cancer for the first 
time but had not undergone treatment when recruited to participate in the study. Those who 
participated in this study were at varying stages between 0-III of unilateral cancer. To 
participate, patients must possess all four limbs, be able to lift their arms laterally by 75, 
and be able to stand on their own for 5 minutes at a time. Patients who had a prior history 
of breast cancer and its associated treatments (i.e. axillary surgery or radiation) were 
excluded from this study. Breast cancer diagnoses of inoperable cancer, stage IV, and 
bilateral disease were not included.  Patients were all measured pre-operatively and post-
operatively at least once.  
 There were 106 patients screened based on reviewing the charts from of the breast 
clinic at Grady Memorial Hospital, who were eligible to participate in the study. Eighty-
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three patients either declined or missed their appointment and therefore could not be 
recruited. The other 23 patients were recruited and consented. Two patients withdrew prior 
to completing the study. The personal and cancer history of the remaining 21 patients were 
summarized in Table 5. Seventeen patients had pre-operative scans that could be processed 
to calculate volume. Six patients had pre-operative scans that could not be processed due 
to articles of clothing covering portions of the arm; therefore, accurate measurements could 
not be performed. A final fifteen patients had post-operative scans, while others were lost 
in the follow-up process and thus, a post-operative scan was missing for those patients. 
Table 5 Grady participant characteristics (n=21) 


















     Partial mastectomy/lumpectomy 
     Total mastectomy, unilateral 
     Total mastectomy, bilateral 




     9 (42.9) 
     5 (23.8) 
     3 (14.3) 
     4 (19.0) 
 
3.3.1.2 Measurement Acquisition 
The arm was measured with two techniques: the tape measure circumferential 
measurements and the Kinect IR system. 
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 The tape measure circumferential measurements were performed by positioning the 
patient lying down on her back on a table. A tape measure was taped down starting at the 
ulnar styloid up to the shoulder. With a second tape measure, circumferential 
measurements were recorded at every 4cm starting at the ulnar styloid and up to the 
shoulder.  
 The Kinect IR system was performed in the same procedure described in 3.2.1.2 
Measurement Acquisition Procedures.  
3.3.1.3 Measurement Processing 
The circumference measurements taken with the tape measure for each patient was 
inputted to calculate the arm volume using the truncated cone technique. The scans from 
the Kinect IR system were processed in the same procedure described in 3.2.1.3 Scan 
Processing.  
 To track the change in arm volumes of each participant through their treatment, I 
normalized change in volume, shown in Equation 1. This measurement was tracked for 
both the side affected and unaffected by breast cancer. To better understand the difference 
of these changes, the difference between the normalized change in the affected arm and the 
normalized change in the unaffected arm was determined, as seen in Equation 2. 




Equation 1 Normalized Change in volume over Cancer Treatment 
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Equation 2 Difference in Normalized Volume Change over Cancer Treatment 
3.3.1.4 Statistical Analysis 
Linear regression analyses were performed to determine the level of correlation 
between the tape measure method and the Kinect IR system. Additionally, to assess the 
agreement of the tape measure method and the IR system, a Bland-Altman plot was 
generated, where the circumference and volume of the right and left arms from Kinect were 
subtracted from the circumference and volume from tape measure method, respectively. 
Data analyses were run using Prism 6 for Windows (version 6.07, GraphPad Software). 
3.3.2 Results 
The arm lengths between the tape measure and Kinect IR system were matched. 
The correlation analysis of the circumferences at 4cm intervals along the arm from the tape 
measure method and Kinect IR resulted in a R-squared = 0.9000 and a slope of 1.035 
(Figure 14A). Similarly, the volume calculated using the tape measure circumferential 
method and the Kinect IR system resulted in a R-squared = 0.8518 and a slope of 1.057 
(Figure 14B).  These correlations of determination indicate that the circumferences and 
volumes are highly correlative between the two measurement methods. As the slope 
approaches 1.00, the two methods near perfect agreement.  
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Figure 14 Correlation of Circumference and Volume 
 For this study, there were three operators that were trained to take measurements 
with the tape measure and the Kinect IR system. Breaking down the volume correlation 
based on each operator, there is some variation (Figure 15). The coefficients of 
determination were comparable to that between Perometer and the Kinect IR system for 
two out of the three operators.96  
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Figure 15 Correlation of Volume segmented by user 
The Bland-Altman agreement analysis resulted in fair agreements between the tape 
measure and the Kinect IR system. The absolute circumference agreement analysis resulted 
in a difference of 1.086 ± 2.249cm (Figure 16A), and the volume agreement analysis 
resulted in a difference of 153.1 ± 264.5mL (Figure 16B).  
 
Figure 16 Bland Altman Plot of Circumference and Volume 
 For the 15 patients with a follow-up scan, the normalized change in volume for the 
affected and unaffected breast cancer sides were analyzed over time. On the affected side, 
 53 
most patients experienced an increase in volume of approximately 10%. Compared to the 
affected side, the unaffected side had more patients that experienced smaller volume 
changes, and more patients that experienced a reduction in volume post-surgery. To see 
how one side changed compared to the other to ensure that changes were not due to overall 
body change such as weight gain or loss, the difference in change in normalized volume 
was calculated. Again, most of patients saw a modest increase in volume in their affected 
side. The single, known lymphedema patient that was diagnosed with lymphedema at a 
lymphedema clinic had the largest difference in normalized change in volume. Statistical 
analyses were not performed due to low sample set.  
 
Figure 17 The normalized changes in volume for the A) affected cancer side and the B) 
unaffected cancer side were tracked over time post-cancer surgery. C) The difference in 
the change in volume of breast cancer patients were tracked over time.  
3.3.3 Discussion and Conclusion 
Currently, prospective surveillance among breast cancer patients pre- or post-
treatment is not performed. This lack of surveillance is due to a combination of the 
difficulty in performing such measurements without either significant financial investment 
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or significant training for the clinical staff and the non-ubiquitous collection of this data in 
the field that leads to the lack of measurement. The Kinect IR system was tested in this 
environment against the tape measure method and was shown to be a strong candidate for 
implementation. The measurements performed with the Kinect IR system were quicker and 
easier to collect by the operators. The correlations of the volumes of each method taken by 
each individual operator indicated that there was variability among tape measurement 
skillsets.  
Variability was shown in the correlation between the tape measure and Kinect IR 
system volume measurements among the operators. This variability in volume correlations 
is speculated to be due to the tape measure circumferential measurement. Many previous 
studies showed that the tape measure method requires training and experience to minimize 
intra-operator variability, much less inter-operator variability.73 
The Bland-Altman agreement analysis showed that if measurements are made with 
both the tape measure and Kinect IR system, there would need to be an offset used in order 
to compare circumferences and/or volumes. In general, the tape measure reported larger 
circumferences and volumes. It is also interesting to note that at larger circumferences and 
volumes, the differences in metrics between the two modalities become larger, indicating 
that there is more variation among larger arms. This variability could be a result of the arm 
shape being difficult to measure with the tape measure because of various surface textures 
or due to either arm shape deviating from the circular or ellipse cross-section assumption 
when calculating volume.  
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Unexpectedly, enrollment into the study was low with less than 22% enrolled. It is 
hypothesized that the need to move to a different room to have the measurements taken 
negatively impacted the enrollment. Patients stated they did not want to lose their place in 
the checkout process at the end of their visit, despite stating that participation had no impact 
on their place in checkout. A more portable system would be ideal in clinical environments 
where checkout processes are less visible to patients. If the system was fully integrated into 
the workflow, then the patient would be less inclined to refuse measurement with the 
system. 
While the majority of patients had at least a single follow-up measurement, 
consistent follow-up measurements were difficult and depended on the number of surgical 
follow-up appointments. The eight patients with no post-treatment measurement were a 
result of logistical challenges in followings patients to their post-treatment follow-up. 
Many of the surgeons of patients enrolled in the study perform a single follow-up, and the 
medical oncology team performed the subsequent follow-ups. Since the medical team is 
separate from the surgical oncology team and located in a different wing of the hospital, 
this study was limited in the number of follow-up measurements taken. This study’s next 
steps would be to involve the whole oncology team for the patient so more longitudinal 
measurements could be performed. For the unilateral cases, having longitudinal data would 
provide enough information to note any asymmetrical arm changes over time. This richer 
dataset could provide insight into how well the metric of difference in change in normalized 
volume of the affected and unaffected cancer side would perform in detecting potential 
lymphedema cases. Then, patients could promptly be referred to a lymphedema trained 
therapist to treat lymphedema before the disease progresses too far.  
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 The Kinect IR system was implemented in a busy, public hospital setting to test 
whether breast cancer patients could have their arms monitored in a longitudinal setting. 
This system is low-cost and has been shown to highly correlate with the previously 
developed Perometer system.96 While this pilot study highlighted logistical challenges, the 
enrollment size would need to increase in order to gather more longitudinal data of pre- 
and post-treatment measurements, which can provide information regarding how swelling 
progresses over time after treatment. The next iteration of the system would ideally be more 
portable so that the measurements could be performed in the patient’s room. This change 
would ease the follow-up measurement process. Ultimately, this implementation into the 
hospital workflow could allow for detection of lymphedema and referral for lymphedema 
treatment.  
3.4 Objective 1C: Exploring the implementation of infrared sensor system for 
monitoring leg lymphedema in a rehabilitation clinic 
 Lower limb lymphedema may be a permanent and debilitating disease that severely 
impacts one’s QOL.10,97 There are various methods of clinically diagnosing and measuring 
lower limb lymphedema, but the most common is taking a volumetric measurement98 or 
assessing signs and symptoms68,99.  A common tool used to measure leg volume is with a 
tape measurement taking the circumferences along the leg at evenly spaced intervals.100 
This technique is time and labor intensive. While the “gold standard” for volumetric 
measurement is water displacement, the challenges regarding hygiene have resulted in 
limited to no use in clinics.62 Various systems have been developed for upper extremity 
lymphedema using infrared technologies that require different numbers of sensors or 
rotation during scan acquisitions, which can be difficult to implement in clinics.78–
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80,82,84,85,101 The commercially available Perometer is available in a horizontal and vertical 
version; while the vertical model aids in the consistency of leg measurements, the frame 
size of 47cm limits the size of leg lymphedema that can be measured.  
Traditional assessment of lymphedema treatment outcomes has been measured by 
some reduction in volume, and details like circumferential changes over time have not been 
used.102 Volume measurement alone is a generalization of the lower limb and does not 
assess the uniformity of reduction or lack thereof. Recently, a study assessed the treatment 
of intermittent pneumatic compression by comparing lower limb circumferences over time 
at five specific levels along the leg.45 More granularity would provide more detail, but the 
five segments were a good start to understand where the volume reduction occurs.  
This study aims to show how a single stationary Kinect IR sensor with a custom 
image processing algorithm can be a tool implemented in a clinical setting to measure 
changes in response to therapy of lower limb volume of leg lymphedema patients with the 
requisite clinical accuracy. The system is easy-to-use, has a small footprint, is non-
invasive, and is quicker than the traditional tools used for circumferential measurements. 
A larger number of circumferential measurements within a limb can be obtained without 
the extra time that would be involved with using standard methods such as the tape 
measure. This inexpensive alternative reduces not only cost but also time and has a small 




Men and women who suffered from various stages of lymphedema and were 
undergoing physical therapy at BenchMark Rehab Partners, LLC, were recruited for this 
study. The inclusion criteria required the participant to be able to stand on their own for at 
least one minute and to possess all four limbs. While all adults were eligible, no minors 
(<18 years old) were recruited for this study. Patients receiving physical therapy treatment 
at BenchMark were recruited for this study by the therapist at the center based on the 
criteria. Prior to participating in the study, all interested patients provided a written 
informed consent.  
3.4.1.2 Physical Therapy Protocol 
Lymphedema treatment is varied among each patient depending on diagnosis and 
treatment needs. There are a few consistent components that each patient can use for 
treatment: education, compression, skin care, exercise, manual therapy, and volumetric 
measurements. Each patient was measured at the beginning of therapy for baseline volume 
of affected and unaffected extremities. The involved extremity was then measured weekly 
to determine differences in volume and changes in size. The patient was then treated with 
compression bandaging of the leg from distal to proximal, to increase the efficiency of the 
veins and lymphatics for volume reduction. Patients then began exercises that will increase 
muscle pump action and hypertrophy of muscles to push against the bandages.103 Manual 
therapy was also applied to further increase lymph volume uptake. Volumetric 
measurements were done only on the affected leg after the first week, but if both were 
affected then both were measured each time. When volume reached a plateau or had 
clinically reduced to normal or near normal volumes, the patient was then measured for 
appropriate compression garments. 
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3.4.1.3 Measurement Acquisition 
Recruited patients were measured at each visit upon consent by a certified therapist 
with the tape measure, which was the clinic’s standard method of measurement, and the 
Kinect IR system. This study was approved by the Institutional Review Board at the 
Georgia Institute of Technology (IRB H15203). Single point and longitudinal 
measurements were gathered at BenchMark. The patients were asked to remove socks, 
shoes, and pants that would obscure the leg measurements; ankle socks were permitted. 
For the Kinect IR system measurements, the patient was asked to walk to the 
delineated spot on the ground (about 1.8 m in front of the sensor). The feet were spaced 
about shoulder width apart to ensure separation of the legs as seen in Figure 18. When in 
the correct positioning, the software interface visually indicated this correct positioning by 
painting the cartooned version of the patient blue. In the background, there were parameters 
built in to ensure that the legs were fully separated, although actual separation becomes 
more difficult to achieve with larger volume legs. When in an incorrect positioning, the 
cartooned patient in the software display would be painted red. The patient was scanned 
from the front (Figure 18A), left side (Figure 18B), back (Figure 18C), and right side 
(Figure 18D) in this body positioning for approximately 30 seconds per side. Ten frames 
per side were used to calculate leg volumes post-hoc, and the process is further described 
in the next section.  
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Figure 18 Kinect IR system leg scans. The (A) front, (B) right, (C) back, and (D) left 
scans are used to calculate the right and left leg volumes. 
When taking measurements with a tape measure, the patient was positioned on a 
table, where the trained therapist could take circumference measurements every four 
centimeters along the leg, starting at the ankle. 
3.4.1.4 Scan Processing – Volume Calculation 
Kinect IR System 
Leg volumes were calculated from the point clouds gathered by the Kinect IR 
system (Figure 18A-D). To compare the volumes calculated with the Kinect IR system 
with the volume from the tape measure measurements, the leg of the IR scan was truncated 
so that the length of the leg matched the length determined by the therapist measurements. 
First, the right and left legs were segmented in the front and back scans with customized 
code. More specifically, the code identified the location where the legs anatomically meet 
and isolated the left leg and right leg in each of the front and back scans. If the leg length 
captured with the tape measurements was longer than the scan’s leg length, then the code 
produced an error message, because it was assumed that there was not enough separation 
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between the legs during the scan to enable complete isolation of the legs. In such an 
instance, the legs were manually isolated by visually determining the boundary between 
the two legs.  
Once the right and left legs were segmented, the legs were truncated to match the 
leg length defined by the tape measure method. First, the legs were truncated at the ankle, 
set at 10cm from the ground to match the tape measurement protocol, and then up the leg 
at the y-coordinate equal to the sum of 0.1m and the tape measure leg length. The boundary 
points of the individual legs were identified and were smoothed using a 5-point moving 
average filter, resulting in a point cloud of the right and the left leg from the front and back 
scans.  
Once the left and right legs were segmented and truncated in the front and back 
scans, the diameters (represented by the dotted yellow lines in Figure 1) were calculated 
by taking the difference of the x-coordinate of inner and outer boundaries (represented by 
the solid red and dashed green lines respectively in Figure 1) of each leg at every 1cm 
interval along the leg. The average of the diameter calculated from the front, dfront, and 
back, dback, scans was used to determine the major axis of the ellipse used to calculate the 
circumference at each axial location on the leg. The diameters from the left and right leg 
scans, dside, were used to determine the minor axis of the respective leg. These diameters 
were calculated by finding the distance between the front and back boundary along the leg. 
The ellipse circumference formula Equation 3 uses the radius of the major and minor axes 
to calculate the circumference of the leg at each location, i, along the leg.  
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𝑐𝑖𝑟𝑐𝑢𝑚𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑖 = 𝜋 ∗ (0.5 ∗ ((𝑑𝑓𝑟𝑜𝑛𝑡,𝑖 + 𝑑𝑏𝑎𝑐𝑘,𝑖) + 𝑑𝑠𝑖𝑑𝑒,𝑖)) 
Equation 3 Leg circumference based on the ellipse formula 
To compare to the tape measure method, the disc method was used to calculate the 
volume at 4 cm intervals using the circumferences calculated previously. The disc method 
formula uses the area of each slice taken every 4 cm and multiplies it by the length (4 cm) 
to calculate the volume of that segment. These segments are summed to give the total 
volume. Subsequently, percent volume difference and volume difference were calculated 
based on the right and left leg volumes.  
Tape Measure 
The leg volume was calculated from the circumference measurements taken with 
the tape measure every 4 cm by a trained therapist. Circumference values were input into 
software by Academy of Lymphatic Studies (ACOLS) to calculate the volume, which is 
based on the disc method, and the resulting percent difference in volume and volume 
difference. 
Other Clinical Measures 
 Clinical metrics used are percent volume difference and volume difference. The 
ACOLS software calculates these metrics based on the affected side in unilateral cases and 
the larger side in bilateral cases. For better comparisons with the Kinect IR system, I 
recalculated these metrics. Volume difference was the right leg volume subtracted by the 
left leg volumes, and the percent volume difference is the volume difference divided by the 
right leg volume multiplied by 100%. 
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3.4.1.5 Leg Change over Therapy 
To assess how volume changed along the leg in response to routine treatment, 
changes in volume were tracked from one visit to the next using both modalities. I 
calculated the average absolute percent error of volumes, which was 6.5%, between the 
tape measure method and the Kinect IR system. Based on this threshold, each leg was 
classified as having undergone (a) no change or less than 6.5% change in either direction, 
(b) increased in volume by 6.5%, or (c) reduction in volume by 6.5% over the course of 
therapy. Then, the change in circumference was calculated between the initial and last 
therapy visit. Using the measurements taken with the Kinect, change in circumference was 
calculated as the difference in circumferences measured at the first and last visit, divided 
by the circumferences in the initial visit, and multiplied by 100%: 
𝐶ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑐𝑖𝑟𝑐𝑢𝑚𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑥 =  
(𝑐𝑖𝑟𝑐𝑖−𝑐𝑖𝑟𝑐1 )
𝑐𝑖𝑟𝑐1
∗ 100%   
Equation 4 Change in Circumference over therapy 
Where x represents the position along the leg, circi represents the circumference at the last 
visit and circ1 represents the circumference at the initial visit. 
3.4.1.6 Statistical Data Analysis 
Linear regression analyses were performed to compare the degree of correlation 
between the Kinect IR system and the tape measure for leg circumference, leg volume, 
percent volume difference, and volume difference. To assess the agreement of the two 
methods, a Bland-Altman plot was created for circumference and volume. This plot is 
composed of the percent difference in either circumference or volume ([Tape Measure – 
Kinect IR system] / average volume) over average circumference or volume of the two 
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modalities, respectively. To evaluate circumferential changes along the leg, the Wilcoxon 
matched-pairs signed rank test with a Bonferroni correction was performed on positions 
with three or more samples to determine whether statistically significant changes in 
circumferences occurred across the patient population. For patients with a reduction in leg 
volume, the modified alpha was 0.0011, and for those with an increase in leg volume, the 
modified alpha was 0.0005. All the analysis was performed using Prism 8 for Windows 
(version 8.0.2, GraphPad Software).   
3.4.2 Results 
Thirty-eight (38) patients at a range of time points of post-lymphedema onset had 
leg lymphedema and participated in the study (Table 6). The patients were composed of 12 
males and 26 females. Of the participants, seven were unilateral cases and 31 were bilateral 
cases. Fifteen participants had a single visit, and 23 participants had more than one visit, 
averaging 3.9 visits over the duration of 25 days (3.5 weeks).  
Table 6 Benchmark participant characteristics (n=38) 











The standard tape measure circumference measurement method and the Kinect IR 
system were compared. The correlation of leg circumferences and correlation of volumes 
along the leg between the two modalities were strong with an R-square = 0.9522 (Figure 
19A) and R-square = 0.9847 (Figure 19B), respectively. The linear regression coefficients 
comparing circumferences and volumes from the two modalities were 1.028 and 1.067, 
 65 
respectively. An R-square value of 1.000 would indicate perfect correlation between the 
tape measure and the Kinect IR system, and a coefficient of 1 with an intercept of 0 would 
indicate perfect agreement. The agreement analysis resulted in a circumference percent 
difference bias of 1.492 ± 6.302% (0.3971 ± 2.601cm) (Figure 20A) and a volume percent 
difference bias of 3.558 ± 7.888% (50.39 ± 518.2mL) (Figure 20B) between the tape 
measure and Kinect IR system. A bias of 0.000 would indicate perfect agreement between 
the two modalities. Additionally, I assessed the correlation of clinically relevant metrics 
such as percent volume difference and volume difference. The analysis resulted in fair 
correlations for percent volume difference with an R-square = 0.6282 (Figure 21A) and 
volume difference with an R-square = 0.6518 (Figure 21B).  
 




Figure 20 Bland Altman Plots of leg circumference and volume 
 
 
Figure 21 Percent volume difference and volume difference 
Interestingly, I noted that a change in leg volume did not change uniformly along 
the leg over the course of therapy. There were 23 participants that had more than one 
measurement, meaning 46 legs were analyzed to assess change from therapy. While 23 
legs had no notable changes in volume, meaning changes less than 6.5%, five legs 
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increased in volume and 18 legs had a reduction in volume. For legs that underwent a 
reduction in volume, the largest reduction in leg circumferences were distal to the body, 
closer to the ankles. Specifically, there was significant reduction in circumferences when 
comparing the changes at 4cm from the ankle to 24cm (p = 0.0007) and 28cm (p = 0.0001), 
8cm to 32cm (p = 0.0090), and 12cm to 32cm (p = 0.0090) up the leg (Figure 22A). For 
legs that increased in total volume after therapy, the greatest changes were found at the 
most distal and most proximal of the leg to the body, but these regional changes were not 
significantly different. 
 
Figure 22 Circumference Change in Legs with Volume Change greater than 6.5%. (A) 
Legs had a reduction in leg volume and (B) legs had an increase in leg volume.  
 For legs with a reduction in leg volume greater than 6.5%, I analyzed the percent 
change in circumference taken by the Kinect system in Figure 23. While there was no 
difference found in the percent circumference change in patients with bilateral 
lymphedema, there was a significant difference found when comparing regional leg 
circumference changes of patients with unilateral lymphedema. Specifically, at 4cm above 
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the ankle, there was significant reduction in circumference compared to the circumferecnes 
at 24cm (p=0.0391) and 28cm (p=0.0234) above the ankle.  
 
Figure 23 Reduction in leg volume for (A) unilateral cases compared to (B) bilateral cases 
of lymphedema 
3.4.3 Discussion and Conclusion 
While there are methods to track lymphedema in its progression and its response to 
physical therapy treatments, there is room for technological improvement to aid with 
clinical implementation to save time and to promote continued monitoring. This study 
shows that circumference and volume strongly correlated when comparing the tape 
measure method and the Kinect IR system. Also, in this study, the therapist collected all 
the scans after a brief training session during regular patient treatment visit, which indicates 
that clinical implementation is realistic and logistically possible with minimal training. 
The Kinect IR system has various strengths and weaknesses. The system is quick 
and requires less training to operate. While length of time for acquisition was not 
specifically recorded in this study, other studies have shown that tape measurements of the 
leg circumferences can take up to 7.5 minutes87, in comparison the Kinect IR system 
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currently takes an estimated 4-5 minutes but was shortened with increased familiarity and 
could be further shortened by reducing the number of frames taken of each side. This time 
savings provides the therapist with time to focus on therapy as opposed to making manual 
measurements with the tape measure. Additionally, this study assessed whether the changes 
in limb volume over the course of therapy was uniformly distributed on the leg. This 
granularity of detail can help inform therapists of which locations within the limb are being 
particularly responsive to therapy and can also identify potential problem areas where fluid 
is not sufficiently draining. While there are many strengths, there are also a few limitations 
to the system. The system results in a slightly weaker correlation when the circumferences 
(>60cm) and volumes (>7000mL) are larger. This limitation is also reflected in the 
agreement analysis, as the differences between the two modalities are larger for limbs with 
larger circumferences and volumes. This data may indicate that at these larger 
measurements, the leg shape may deviate from the assumed cross-sectional shape. 
Many studies have reported various ways of assessing effectiveness of treatment of 
lymphedema with volumetric measurements being the most common100,102. There are 
multitudes of modalities to measure volume that vary in financial cost, labor intensity, 
hygienic risk, and length of testing. Interestingly, there has been little attention on the 
assessment of more regional changes over the course of therapy to gain a better 
understanding of where changes in swelling occurred. The Kinect IR system balances its 
cost with the reduction in scanning time and reduced training for acquisition. It is worth 
noting that this model of the Kinect IR sensor has been discontinued, but other comparable 
infrared sensors can be integrated with the software, and thus the approach of applying 
detailed morphological analysis of 3D point clouds to determine localized volume changes 
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in response to therapy is agnostic to the particular sensor being used. A study has shown 
promising volume measurements using portable infrared technology among filarial 
patients in Sri Lanka that can be translated for lymphedema patients under therapy.87 In 
fact, this new scanner technology (LymphaTech, Atlanta, GA) has replaced the use of the 
Kinect scanner in the clinical implementation of limb volume tracking at BenchMark 
Rehab Partners in Chattanooga, where the data presented here was collected.   
Assessing regional circumferential changes along the legs under treatment for 
lymphedema in this study showed that the resulting volume reductions were not uniform 
along the leg. While volume has been a good indicator of efficacy of the treatment, this 
approach does not detail whether reduction occurs uniformly along the leg or in specific 
regions. Therefore, analyzing specific regions provides more granular information that can 
inform future treatments. The results showed that when analyzing regional changes over 
the course of therapy for lymphedema, there was significant reduction of leg volume at 
regions more proximal to the body. Legs that underwent an increase in volume over time 
had no significant regional differences in volume change, but because this increase was a 
rare event in the study, the sample size of this group was very small and likely 
underpowered. While assessing changes in this small set of patients, volume increases 
seemed to occur at the most proximal and distal regions of the leg, which correlates to 
where the therapeutic compression garment ends. Additionally, fluid buildup in the leg 
despite therapy could be an indication of lymph blockage more downstream to the leg. In 
addition to informing therapists of where the leg is responding to therapy, this 
implementation could expedite the overall duration of therapy for volume reduction, and 
future studies could investigate its potential in this regard. 
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The Kinect IR system is a good alternative to the tape measure method used in clinics 
to monitor the change in leg volume over the course of therapy. It is capable of tracking 
patients over time. Again, this system is low-cost and highly correlates with the tape 
measurement method. Furthermore, all these scans were collected by the clinician, 
demonstrating the ease of use and implementation in the clinic. Because of the time-
consuming nature of measuring with a tape measure, non-affected legs were measured only 
at the initial visit and are assumed to be constant over the course of therapy. This Kinect 
IR system quickly measures both legs; any changes in the non-affected leg could 
potentially be informative with general body changes. In the next steps, analysis of local 
changes in the leg to inform treatment could show whether this approach could result in 
greater reduction in the affected limbs.  
3.5 Conclusion 
Through this aim, I explored the implementation of the Kinect IR system in multiple 
clinical settings. The clinical environments ranged from specific rehabilitation centers to a 
large public hospital. Participants included lymphedema and non-lymphedema cases of the 
arms and legs. While arm lymphedema patients were all unilateral cases, leg lymphedema 
cases included unilateral and bilateral cases. The Kinect IR system measurements were 
taken either by the researcher or the clinician involved in the specific study. Comparisons 
were made with the clinic’s measurement standard, either the Perometer or the tape 
measure circumference measurement method.  
 Through these studies, the analysis showed that the Kinect IR system correlated 
and agreed well with the clinic’s measurement standard. In addition, the Kinect IR system 
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was quicker, taking no more than 4-5 minutes to collect measurements, and was easier to 
operate. The implementation into the rehabilitation clinic’s workflow had fewer challenges 
due to more spatial area. The patient population in these environments was also educated 
about lymphedema since they were further along in their oncology journey. Challenges in 
the hospital study indicated factors that, if changed, would ease the implementation process 
such as portability.  
With the discontinuation of the Kinect IR sensor model, the system was updated. The 
next iteration went from a Kinect IR sensor connected to a computer (Figure 4) to the 
Structure sensor connected to the iPad mini 2 (Figure 5). While the cost of the system itself 
remained approximately the same, there were many benefits with the second iteration of 
the system. The Structure system is more portable and completely handheld. Arm patients 
rest their hands on a stand during the scanning process, eliminating fatigue associated with 
holding the arms in the air and minimizing any motion associated with fatigue. 
Additionally, a single arm is scanned at a time reducing the amount of open space necessary 
to acquire scans. Although the arms are scanned separately, the overall measurement time 
remains approximately the same, taking about 1 minute of scan time per arm. This system 
outputs a high-resolution 3D scan of the arm, as opposed to partial scans resulting from the 
Kinect IR system. As a result, there are more opportunities to explore questions regarding 
lymphedema. With the right dataset, I could explore if there are other measurements that 
can be more meaningful when identifying limbs with lymphedema.  
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CHAPTER 4. AIM 2 
4.1 Introduction 
Traditional methods of diagnosing and monitoring lymphedema use volume of the 
limb. Because prospective surveillance is not standard among the patients who are at risk, 
there is no baseline measurement of volume when the patient goes into therapy. With no 
baseline, it can be difficult to detect lymphedema. Common alternatives such as volume 
difference, where both arm volumes are compared, can detect unilateral lymphedema, but 
significant swelling must occur before bilateral lymphedema is detected as both limbs 
could swell simultaneously.  
Studies have explored features aside from volume in conjunction with the use of 
machine learning to detect lymphedema in patients. Moreira et al. evaluated upper body 
function and its ability to classify lymphedema in patients from non-lymphedema 
patients.77 They showed features such as range of motion and arm widths had greater 
influences in its functional assessment. More recently, the Fu group has developed a model 
that takes in self-reported symptoms, and clinical analytics to predict lymphedema appears 
promising with nearly 94% accuracy, 96% sensitivity, and 91% specificity rates.104 
Meanwhile, Armer et al. showed that continued surveillance of both limb measurements 
and symptoms is critical as lymphedema incidences can present as volume changes despite 
lymphedema symptoms decreasing.105 New measurements for detecting lymphedema are 
intriguing and a viable approach.  
New approaches can take advantage of technological advances and utilize 3D scans 
taken by infrared sensors. Rather than assessing global metrics like volume, more detailed 
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local geometries can be explored.84 To determine whether these local geometry 
measurements have any potential value, I assessed the measurement’s capacity to classify 
lymphedema patients and their arms by training and testing classification models. 
Ultimately, the final model can be used in clinics with limited lymphedema background 
and specialization seeing patients who are at risk for developing lymphedema.  
 In this aim, features were engineered based on metrics that are descriptive of the 
local anthropometric geometries of the arm. Healthy and lymphedema arms undergoing 
therapy were scanned using the second-generation system using the Structure sensor and 
LymphaTech acquisition software. These features were used to train classification models 




All women in this study previously had breast cancer and underwent treatment at 
least once. Their physicians referred these women to TurningPoint Breast Cancer 
Rehabilitation for post-treatment rehabilitation. Those who participated in this study were 
at various stages post-treatment of breast cancer and were undergoing rehabilitation for 
varying periods of time ranging from new patient to returning patient for many years.  
 Women who were receiving physical therapy treatment from TurningPoint Breast 
Cancer Rehabilitation were recruited for this study by the therapists based on the inclusion 
and exclusion criteria. All participants were required to be adult (18 years or older), female 
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breast cancer survivors, who may have undergone any combination of surgery, 
chemotherapy, and/or radiation. Participants must have all four limbs and must be able to 
stand without assistance for one minute. These women did not have to be diagnosed with 
lymphedema to participate. All patients provided a written informed consent prior to 
participating in the study. 
4.2.2 Structure Measurement 
Participants were scanned once per side, totalling twice including the right and left 
sides, with a single Structure sensor (Occipital, Boulder, CO) mounted on an iPad Mini 2 
(Apple Inc., Cupertino, CA) as seen in Figure 5. Women were asked to wear taut sleeveless 
tops and to remove jewelry on their arms, although rings were permitted, to ensure that the 
wrist to axilla region was unobstructed.  
 Participants were asked to stand with a single arm raised and extended to create a 
90-degree angle with the body, resting their hand on a pole adjusted to the height of their 
axilla. As the participant stands still for approximately one minute, the scanner panned the 
Structure device around the arm of interest to capture the 3D scan (Figure 24). As the sensor 
collected depth data of the arm, the LymphaTech software paints over the completed area 
with a solid color, differentiating it from what is remaining to be captured. Each arm was 
scanned, resulting in two .OBJ files of the right and left arms per patient. The session per 
patient took at most 5 minutes from positioning the participants to completion. The 
lymphedema status of participants was reported by the participant’s caring therapist. 
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Figure 24 Structure system arm scan 
4.2.3 Feature Development 
The .OBJ files were pre-processed in two major steps for feature engineering. 
Firstly, the point cloud needed to be segmented to capture only the portions of the arm 
between the shoulder and the wrist, which would be used for further analysis. The .OBJ 
file collected was read into Matlab R2017b as an object composed of an array of vertices 
and their corresponding normals in the x-, y-, and z- components (Figure 25A). Because 
the scan captures portions of the trunk and the hand in addition to the arm, defined as the 
wrist to the shoulder, the object was truncated. This process included identifying the axilla 
(associated with the shoulder position) and the wrist as described below. Next, this arm 
.OBJ was inputted into a feature extraction code that outputs a list of features extracted. 
Extracted features were used as inputs to train a model.   
4.2.3.1 Data Segmentation 
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The region of interest is the arm bounded by the wrist and the axilla. The axilla 
detection was automated by rotating the object by 5π/6. The rotation ensures that the axilla 
is located at the maximal y-coordinate point. A boundary line was created to represent the 
underside of the arm, and the point associated with the maximum y-coordinate in this 
boundary corresponded with the axilla location, denoted as the blue circle in Figure 25B. 
The original point cloud was filtered so any x-coordinate greater than the x-coordinate of 
the axilla is removed, where along the x-coordinate the object starts from the hand and 
moves to the wrist, elbow, axilla, and then trunk (Figure 25C). Next, the object was rotated 
back to its original orientation, and the wrist is identified. 
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Figure 25 Process of removing the trunk. A) Plots the original .OBJ file showing that the 
pole, hand, arm, and trunk of the patient is captured. B) The object is rotated for 
automated axilla identification, where the axilla is represented by the blue circle (“o”). C) 
The body/trunk is identified and removed from the object file, leaving the pole, hand, and 
arm. The blue circle represents the identified axilla again.  
 The wrist was manually identified by the researcher three times at spaced out 
intervals over the course of two months. The wrist detection was to the closest centimeter, 
to determine the final x-coordinate of the wrist. This wrist identification process was done 
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in an interactive figure display, where the user could rotate the .OBJ (of the hand through 
the axilla) and then clicked on the wrist region in the .OBJ displayed. The x-coordinate to 
the nearest centimeter of the location of the click was recorded. Of the three identifications, 
the final x-coordinate of the wrist was determined based on the following rules. If there 
was one unique x-coordinate, then it became the final x-coordinate. If there were two 
unique x-coordinates, then the mode of the x-coordinates was taken for the final x-
coordinate. If all three x-coordinates were unique, then the median x-coordinate was taken 
as the final x-coordinate. These outcomes were summarized in Table 11. The final x-
coordinate of the wrist was recorded and inputted in the TruncateArm_FINAL.m (A.1.1
 TruncateArm.m) function to output the final .OBJ file of the arm from the wrist to 
the axilla visualized in Figure 26.  
 
Figure 26 A representative image of a point cloud of an arm from the shoulder to the 
wrist. 
Despite best efforts to position arms parallel to the ground, some scans of arms 
were sloped and non-aligned as seen in Figure 27A, where the left arm point cloud is in 
yellow and the right arm point cloud is in blue. Therefore, the arms were aligned. This 
alignment started by generating a cylindrical point cloud centered around the positive x-
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axis. The left and right arm point clouds were aligned to this cylinder using a point-to-point 
iterative closest point (ICP) algorithm, which used the cylinder as a fixed point of reference 
seen in Figure 27B. This step transformed the arm point cloud to be parallel to the x-axis. 
The left and right arm point clouds were transformed by rotating and translating the point 
clouds to match the cylinder reference. The transformation process iteratively minimized 
the error, which is the sum of the squared differences between the coordinates of the 
matched pairs of the left and right arm point clouds with the cylinder point cloud. Lastly, 
the left and right arm point clouds were aligned with each other using the ICP algorithm, 
setting the left arm point cloud as the reference point cloud for the right point cloud. The 
final alignment of the left and right arm point clouds is represented in Figure 27C.  This 





Figure 27 Arm alignment process is represented in these images. A) The image shows the 
initial arm position, where the left arm corresponds to the yellow arm and the right arm 
corresponds to the blue arm. B) The arms are aligned with the cylinder drawn along the 
x-axis before C) the right arm is aligned to the left again for the final alignment. 
4.2.3.2 Transforming Data 
Aside from volume, various metrics were determined to represent local geometries 
that might differentiate a healthy arm versus a lymphedema arm. During the progression 
of lymphedema, the arms change regionally. Therefore, features should also assess specific 
regional changes in metrics to capture non-uniform changes. Table 12 outlines the features. 
The angles of the forearms were calculated based on the first third of the arm from 
the wrist. Two lines were created in both the x-y and x-z planes by fitting a first-degree 
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polynomial via a least-squares approach to the upper and lower edges (blue and red lines, 
respectively in Figure 28) of the arm in that plane. An angle between the two lines, denoted 
in the yellow arc in Figure 28, in each plane was calculated in degrees. Specifically, the 
angle was calculated by taking the inverse tangent in degrees of the upper line and lower 
line, and the sum of the absolute value of the two angles was the final forearm angle.  
 
Figure 28 The forearm angle is denoted by the yellow arc and is formed by the tapering 
of the forearm as the wrist is approached. This figure is a representative image of this 
forearm angle in the x-y plane. The forearm angle was also calculated for the x-z plane.  
The regional curvature data were composed of minimum, maximum, mean, and 
gaussian curvature information for each specific region outlined in Figure 29. These 
features were feasible due to the alignment of the arms so that features of a region of the 
left arm matched that of the right arm. Each arm was divided into 36 regions where 
curvature data was calculated. The arm was segmented in the sagittal plane along the arm 
(in the x-direction) into six segments. Each of these segments was then divided in the axial 
plane into top and bottom halves at the mid-point of the arm. Then, these halves were 
separated into thirds in the coronal plane, creating a front, mid, and back region, where the 
front region corresponds to the anterior side of the body. The various curvature features 
were then calculated for each region.  
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Figure 29 Arm regions for curvature features (minimum curvature, mean curvature, 
maximum curvature, and gaussian curvature) were outlined above for a total of 36 
regions. The arm was divided into six regions in the sagittal plane along the arm in the x-
direction. Each slice was then divided into a top and bottom region at the mid-point of the 
arm in the axial plane. Then, the halves were subsequently divided into thirds in the 
coronal plane, creating a front, mid, and back section where the front corresponds to the 
anterior side of the body.  
The arm scans contained a 3D point cloud composed of vertices, where triangular 
faces exist among the points. The principal component analysis (PCA) was performed on 
these local face centers. This process was an orthogonal transformation of the x-, y-, and 
z-components of the face centers. The covariance was calculated, and the eigenvalues were 
represented as s1, s2, and s3. 
Statistical measurements of features that have an output for each vertex or for each 
slice, set at a thickness of 1cm, along the arm of the scan were calculated to gain a better 
understanding of the feature distribution. Assuming a unimodal distribution, the average, 
median, standard deviation, range, skewness, and kurtosis were calculated. The average 
was calculated by summing the feature at each point or slice and dividing by the number 
of points and slice. The median was calculated by ordering the measurements and taking 
the value in the middle. The standard deviation described the amount of variation that exists 
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from the mean. The range was calculated by taking the difference between the maximum 
and minimum values. The skewness measured the symmetry of the feature dataset, and the 
closer to zero the skewness was, the more symmetrical the data was. The kurtosis measured 
how much of the data fell near the tails of a normal distribution, and a positive kurtosis 
indicates a “heavy-tail” dataset, meaning more data was near the tails or are outliers. A 
negative kurtosis indicates a “light-tail” where the dataset fell near the mean and had few 
outliers. Both skewness and kurtosis were calculated based on the mean, standard 
deviation, and number of points (i.e. the number of vertices or number of slices, depending 
on the feature). 
As mentioned previously, the arm scans are composed of vertices and their 
corresponding normal. Each normal was composed of its x-, y-, and z-components, and 
each component was treated as an individual feature. The unimodal statistical 
measurements were calculated per arm scan, resulting in an understanding of the 
distribution of each feature per arm. When plotting the distribution of the normal y-
coordinate and z-coordinate, the data appeared to have a beta distribution. Therefore, the 
shape parameters, alpha and beta, were calculated utilizing the Matlab function that fits the 
beta probability distribution to the normal y-component and normal z-component for each 
arm scan.    
A curvature was calculated for each vertex in an arm scan. To estimate these 
curvatures, the nine (9) closest points to each vertex was determined by the knnsearch 
function in Matlab. The eigenvectors and eigenvalues were computed for the surface 
created by the nine neighbors and the vertex itself. The estimated curvature was calculated 
by dividing the smallest eigenvalue by the sum of the three eigenvalues.106,107 The 
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unimodal statistical measurements were calculated per arm. In addition, when plotting the 
distribution of the curvatures for each vertex, an inverse gaussian distribution was noted 
and therefore, the shape parameter lambda was calculated utilizing the Matlab function that 
fits the inverse gaussian distribution to the curvatures for each arm scan.  
The perimeter, area, and circularity were calculated at 1cm slice thickness. The 
slices were created by starting at the wrist x-coordinate and binning vertices at every 1cm 
interval. In each 1cm bin, the vertices were plotted in the y-z plane and a boundary function 
in Matlab was applied to create a boundary around the vertices as shown in Figure 30A. 
The function outputs a vector of point indices that represent the boundary around the 
vertices that were input into the function. The shrink factor of the boundary function was 
set to 0.5, which controls how compact the boundary is. Occasionally, the boundary 
function produced an erratic fit, resulting in an incorrect perimeter, area, and circularity. 
Therefore, when the circularity was greater than 2, the shrink factor was set to 0.1.  
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Figure 30 A) The image represents a one cm thick segment of the arm composed of the 
vertices (blue dots) and a boundary that was fit to the vertices (red line). B) This image 
represents when the boundary fit was erratic.  
Based on the boundary output, the perimeter was calculated by summing the 
distance between the points in the boundary output vector. The area was then calculated 
using the polyarea function in Matlab, which returns the area of a polygon that was 
specified by the vertices. Lastly, circularity was calculated based on Equation 5, where a 
circularity value of 1 represents a perfect circle.  
𝑐𝑖𝑟𝑐𝑢𝑙𝑎𝑟𝑖𝑡𝑦 =  
𝑝𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟2
4 ×  𝜋 × 𝑎𝑟𝑒𝑎
 
Equation 5 Circularity equation 
When calculating volume clinically, circumferences are measured at 4 cm intervals, 
which segment the arm into a number of slices equal to the arm length divided by 4 cm. 
This Structure sensor provides point cloud coordinates to the tenth of a millimeter. Volume 
calculations used the disc method, which multiplies the area of each slice by the slice 
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thickness to calculate the slice volume. These slices were summed to compute the total 
volume. 
Traditional slice thickness is 4cm, but this system is capable of calculating volume 
with thinner slices. Therefore, I calculated volume at various slice thickness for every arm 
to determine which thickness is optimal for volume calculations. As the slices became 
thinner, fewer data points from the arm scan were available for the area calculation, and 
thus set a limitation to how thin the slices could be. The slice thicknesses ranged from 0.05 
cm to 10cm. The correlation coefficient was calculated for each paired slice thickness, and 
the results are summarized in the volume correlation matrix in Table 7. Then, it was 
determined that 1 cm provided the best balance between the number of data points per slice 
and the number of slices at fine enough intervals.  
Table 7 Correlation Matrix that represents the correlation coefficients of the arm volumes 
calculated based on various slice thicknesses  
Thickness  
(m) 0.0005 0.0010 0.0050 0.0100 0.0200 0.0300 0.0400 0.0500 0.0800 0.1000 
0.0005 1          
0.0010 0.9981 1         
0.0050 0.8102 0.8006 1        
0.0100 0.5260 0.5076 0.8949 1       
0.0200 0.5859 0.5680 0.9245 0.9910 1      
0.0300 0.5738 0.5560 0.9189 0.9917 0.9972 1     
0.0400 0.5801 0.5631 0.9217 0.9898 0.9961 0.9961 1    
0.0500 0.5719 0.5585 0.9150 0.9864 0.9923 0.9924 0.9921 1   
0.0800 0.5866 0.5715 0.9212 0.9811 0.9884 0.9894 0.9901 0.9881 1  
0.1000 0.5809 0.5657 0.9158 0.9809 0.9879 0.9896 0.9897 0.9873 0.9923 1 
 
To gain a better understanding how different regions of the arm may differ, ratios 
of the perimeters and ratios of the circularities were calculated. In order to do so, the 3D 
point cloud of the arm was segmented into six equal regions similar to the region shown in 
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Figure 29A, resulting in seven locations (represented by the red, vertical lines) where a 
1cm slice was taken and compared to other slices that are more distal (closer to the wrist).  
Additionally, arm length was calculated by taking the difference of the x-
coordinates at the shoulder and wrist. This measurement was used then to calculate an 
average cross-sectional area for each arm by dividing the arm volume by the arm length. 
This measurement can provide a sense of body mass index. For a patient of a specific 
height, arm length is within some range that is proportionate to the patient’s height. 
Therefore, as the volume of the arm for a specified arm length, it can be assumed that the 
patient has a larger body mass.   
Lastly, the shape diameter function (SDF) was computed based on cones of 120 
for each vertex. SDF provided a relationship between the arm volume with its surface 
boundary.108 The cone was centered in the inward normal direction at each vertex, and ray 
are sent within the boundaries of the cone to the other side of the arm. The SDF was 
calculated to be the weighted average of the lengths of the rays that was within one standard 
deviation of the median of all lengths. The unimodal statistical measurements were 
calculated for all the SDF values for an arm scan.   
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Figure 31 Visual representation of a cone of rays. Images are courtesy of Lior Shapira et 
al. (2008).  
The naming nomenclature of the features took the base features (i.e. perimeter, 
circumference, etc.) and appended the statistical analysis (i.e. average, range, etc.). If there 
were specific parts of the arms that were compared, then those were appended to the feature 
name. For the perimeter and circularity ratios, the seven slices were named 1 through 7 
with slice 1 corresponding to the first slice starting at the wrist and slice 7 corresponding 
to the last slice closest to the shoulder. The ratios were calculated so the perimeter or 
circularity of a slice closer to the shoulder is divided by the slice closer to the wrist. Thus, 
a perimeter ratio of “2to1” would mean slice 2 was divided by slice 1 and named 
“periRatio_2to1”. For the regions, the six segments were numbered 1 through 6 starting 
from the wrist (Figure 29A). The top and bottom halves were noted as “T” or “B”, 
respectively. The front, mid, and back thirds would be appended to the end. As an example, 
the front third of the bottom half of region 1 of the gaussian curvature feature would be 
denoted as “curvature_gaussian_RB1front”.  
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4.2.3.3 Feature Development for Patient 
In addition to developing the feature vector for the individual arms, features were 
developed for the patient. The difference between the arms for each feature was calculated. 
The specific differences depended on how the patients were classified. Two approaches 
were taken. I developed a model for two-classes where I defined the dataset into two labels, 
lymphedema and non-lymphedema. A three-class model was developed where the dataset 
was divided into three labels: right lymphedema, left lymphedema, and non-lymphedema. 
For two classes, the difference of each feature was taken between the larger volume arm 
and the smaller volume arm, denoted by appending “DiffLS” to the end of the feature name. 
For three classes, the difference of each feature was calculated between the right arm and 
the left arm, denoted by appending “DiffRL” to the end of the feature name.  
To properly compare features of the right and left arm, the arms should be equal in 
length in order to be able to compare measurements such as volume between the two arms. 
A longer arm may artificially skew features for that arm, and when comparing it with the 
contralateral may exacerbate or reduce the differences seen between the arms. Therefore, 
these arms are matched in length for the feature development process for patient level 
models. Specifically, for the volume feature, the arm lengths of the right and left were 
matched to the shorter arm and the volume was recalculated for the arm that was shortened. 
4.2.4 Classification model 
Models were developed to either classify the patient or the arms. To classify 
patients, two approaches were taken. First, two classes were assumed: the patient either 
was healthy or had lymphedema. The second approach assumed three classes that 
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delineated which arm had lymphedema, resulting in the following classifications: 
lymphedema in the left arm, lymphedema in the right arm, and no lymphedema. With both 
approaches to patient classification, it was assumed that there were no bilateral 
lymphedema cases, which is true for this dataset. Only women at risk for unilateral 
lymphedema or with only unilateral lymphedema were recruited to participate in this study. 
To classify arms, two classifications were possible: healthy or lymphedema. This method 
was implemented because with a patient classification approach, bilateral lymphedema 
cases are missed as a result of both arms undergoing changes. Therefore, if a model could 
classify arms individually without needing to compare to the other arm, then this subset of 
lymphedema patients could be identified. These models were tested and evaluated for their 
ability to classify correctly. 
The dataset was divided into a training set and testing set. The training dataset was 
chosen by using a random number generator with a uniform distribution to identify the 
arms or patients that would be used, and the remaining arms or patients became the testing 
dataset. It is important to note that for this split, the rate of lymphedema was maintained in 
the training and testing sets. For the arm classification, this split was 25% / 75% for training 
and testing. For the two-class patient classification, the split was also 25% / 75% for 
training and testing. Lastly, for the three-class patient classification, the split was 50% / 
50% for training and testing.  
4.2.4.1 Feature Selection 
The features were reduced based on running a statistical test on the difference 
groups. A t-test was performed for datasets of two classifications, and the Kruskal-Wallis 
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test was performed for datasets of three classifications. This step of the analysis was 
performed solely on the training set to ensure that the testing set data did not inform the 
features selected. The alpha threshold was set to 0.10 so any feature with a p-value less 
than alpha was kept and used within the training dataset.  
4.2.4.2 Training Model and Evaluation 
Using Matlab, the training dataset was passed through various standard machine 
learning algorithms with a 5-fold cross validation. This cross validation means that the 
training set was partitioned into five randomly chosen subsets of approximately equal size. 
One subset was used to validate the model that was trained by the remaining four subsets 
per round. This validation was done for each of the five subsets for a total of five rounds 
as illustrated in Figure 32. The average of the errors of each round was minimized to 
calculate the parameters of each feature for the final model.  
 
Figure 32 Five-fold cross validation illustration 
The performance of the trained model was assessed, and the most promising models 
were tested with the testing dataset. Two metrics used to evaluate the potential trained 
models to test were sensitivity and specificity. Sensitivity is the true positive rate or the 
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number of lymphedema cases correctly identified by the model over the total number of 
actual lymphedema cases. Specificity is the true negative rate or the number of healthy 
cases correctly identified by the model over the total number of actual healthy cases. While 
both of these are important, sensitivity is more important as the goal is to be able to identify 
the lymphedema cases for referral to a lymphedema specialist, who can diagnose and treat 
lymphedema onset. Even though specificity was a secondary metric when evaluating the 
model, it was not completely sacrificed because that would be no better than clinically 
assuming everyone would develop lymphedema, which is not the case. Accuracy, which is 
the rate of correctly identified healthy and lymphedema cases, was calculated when 
evaluating trained models, but the metric can be misleading since lymphedema occurs at a 
rate lower than 50%. Therefore, accuracy was also a secondary metric used to evaluate the 
trained model.  
In order to test the classification, the testing set was inputted into the trained models 
and the outcomes were evaluated based on the sensitivity, specificity, and accuracy. As a 
benchmark, the sensitivity, specificity, and accuracy of the clinical metrics, volume 
difference and percent volume difference were calculated and assumed as the gold 
standard. Once the models were evaluated, the features that were used to train the well-
performing models were aggregated.  
4.3 Results 
One hundred (100) female patients participated in the study at various time points 
post breast cancer treatment. While the majority of women did not have lymphedema, the 
thirty-six (36) women who did have lymphedema had unilateral presentation of 
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lymphedema and had been undergoing therapy to treat the swelling. The thirty-six (36) 
lymphedema cases contained twenty-six (26) patients who had swelling in the left arm and 
ten (10) who had swelling in the right arm. These characteristics can be found summarized 
in Table 8. 
Table 8 TurningPoint participant characteristics (n=100) 





BCRL Count (%) 
Clinical  
      Left 
      Right 
200 mL difference 
10% volume difference 
36 (36) 
     26 (26) 




 As described earlier, there are two criteria used with arm volumes to determine 
lymphedema. One of the standard methods of measurement for lymphedema detection is 
the absolute value of the volume difference between the two arms that is greater than 
200mL. For this dataset, the performance of this metric resulted in an accuracy level of 
67%. The sensitivity rate is 33%, and specificity rate is 86%. An analysis of how accuracy, 
sensitivity, and specificity change as the critical value threshold changes is summarized in 
Table 9 and Figure 33. As sensitivity improves, specificity and accuracy rates decline. For 
a sensitivity rate of 50% on this dataset, the critical threshold for volume difference would 
need to be set at 100mL. This threshold also results in a specificity rate of 50% and 
accuracy rate of 50%.  
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Table 9 Critical values for Volume Difference of arms to classify lymphedema 
 
 
Figure 33 Critical threshold value for volume difference (larger arm – smaller arm) and 
the resulting accuracy, sensitivity, and specificity rates as the result. 
The other standard methods of measurement for lymphedema detection is the 
absolute value of the percent volume difference between the two arms of greater than 10%. 
Percent difference was calculated based on the difference of the larger and smaller 
volumes, which are then divided by the smaller arm’s volume. For this dataset, the 
performance of this metric resulted in an accuracy level of 68%. The sensitivity rate is 
27.8%, and specificity rate is 90.6%. An analysis of how accuracy, sensitivity, and 
specificity change as the critical value threshold changes is summarized in Table 10 and 
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Figure 34. Again, as sensitivity improves, specificity and accuracy rates decline. For a 
sensitivity rate of 58.3% on this dataset, the critical threshold for percent volume difference 
would need to be set at 3%, which is below the error associated with many volume 
measurement approaches. This threshold also results in a specificity rate of 28.1% and 
accuracy rate of 42%. These clinical standards were used as the gold standard to compare 
against the models developed. 
Table 10 Critical values (sensitivity, specificity, and accuracy rates) for Percent Volume 




Figure 34 Critical value for percent volume difference for classifying lymphedema. 
Percent different was calculated to be the difference of the larger volume arm minus the 
smaller volume arm, divided by the smaller volume arm. 
4.3.1 Feature Development 
4.3.1.1 Data Segmentation 
When the scans were filtered to ensure that only the arm from the shoulder to the 
wrist were kept, the wrist was manually identified. The three wrist identifications were 
analysed to determine its consistency. The average standard deviation of the three 
identifications for all the scans was 0.44cm. Seventy-two (72) scans had the same x-
coordinate identified as the wrist point for all three attempts. One hundred eleven (111) 
scans had two unique x-coordinates identified as the wrist. Seventeen (17) scans had three 
unique x-coordinates identified as the wrist. The maximum range of x-coordinates when 
manually identified was 3 cm, which occurred for two scans. For twenty-five (25) scans, 
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the range was 2cm. There was a 1cm range for 101 scans. These ranges are summarized in 
Table 11.  
Table 11 Ranges of the x-coordinate deviation from manual identification of the wrist 
Range (cm)  0  1  2 3 
# scans 72 101 25 2 
 
4.3.1.2 Features for Patient Classification 
When the right and left arm lengths were compared, small differences in length 
were found. Most patients in this study had arm lengths that varied less than 4cm between 
the two arms with the majority having a difference less than or equal to 2cm (Figure 35). 
This finding aligned with what clinicians have found anecdotally when measuring arms via 
the tape measurement method, measuring every 4cm; clinicians would measure one arm of 
a patient 4cm longer than the other and would calculate volumes for both arms based on 
the shorter arm length. The same approach was taken in this study when calculating volume 
differences for a patient.  
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Figure 35 Arm length differences (right-left) indicates the majority of patients in this 
study had arms of similar length, with most falling within 4 centimeters of each other.  
4.3.2 Model Results 
The clinical metrics of volume difference and percent volume difference for 
detecting lymphedema were used to calculate how well it would be able to identify healthy 
and lymphedema cases. These outcomes were used as a baseline for the evaluations of the 
trained models. Volume difference between the right and left arm had a sensitivity of 
38.9%, specificity of 89.1%, and an accuracy of 71%. Meanwhile, percent volume 
difference between the right and left arm resulted in a sensitivity of 27.8%, specificity of 
96.9%, and an accuracy of 72%.  
4.3.2.1 Features for Patient Classification 
During the feature selection process of the three-class model, seventeen (17) 
features have p-values less than the alpha threshold. The features and its p-values are listed 
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in Table 13. Of all the trained models, the best performing was the trained quadratic 
discriminant model, which resulted in a sensitivity of 61%, specificity of 78%, and an 
accuracy of 72% (Figure 36). The complete list of trained models and tested models can 
be found in the appendix in Table 14 and Table 15, respectively. Interestingly, when the 
quadratic discriminant model was trained with the same set of features listed in Table 13 
but removing Volume_diffRL, the test dataset performance improved slightly. The 
sensitivity maintained at 61%, but specificity improved to 84% and accuracy improved to 
76%.  
 
Figure 36 Evaluation of performance of trained model to classify patients based on 3 
classes 
I developed two models for identifying patients, one with two-classes and the 
second with three-classes. During the feature selection process of the two-class model, 
three features have p-values less than the alpha threshold. These features and their p-values 
are outlined in Table 16. Of all the trained models, the best performing was the trained 
medium tree model, which resulted in a sensitivity of 44%, specificity of 73%, and an 
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accuracy of 63% (Figure 37). The complete list of trained models and tested models can 
be found in the appendix in Table 17 and Table 18, respectively.  
 
Figure 37 Evaluation of performance of trained model to classify patients based on 2 
classes 
4.3.2.2 Features for Arm Classification 
During the feature selection process, twenty (20) features have p-values less than 
the alpha threshold. The features and p-values can be found in Table 19. Of all the trained 
models, the best performing was the trained RUSBoost tree model, which resulted in a 
sensitivity of 52%, specificity of 72%, and an accuracy of 69% (Figure 38). The complete 
list of trained models and tested models can be found in the appendix in Table 20 and Table 
21, respectively. Interestingly, when the RUSBoosted Tree model was trained with the 
same set of features listed in Table 19 but removing Volume, the test dataset performance 
improved slightly. The sensitivity increased to 55.6%, but specificity decreased to 66.7% 
and accuracy decreased to 64.7%.  
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Figure 38 Evaluation of performance of trained models for arm classification 
4.4 Discussion and Conclusion 
Currently, clinics specialized in lymphedema diagnosis and treatment use many 
inputs to diagnose lymphedema. The greater challenge is ensuring that at risk patients are 
being referred to these clinics prior to lymphedema development. Despite the many 
techniques available to detect and monitor lymphedema, surveillance of patients at risk of 
developing lymphedema is poor. There is a need for a system that can be easily 
implemented in clinics that can help clinicians refer patients to specialized lymphedema 
clinics without large financial investments and with minimal training to know when to refer 
patients. Utilizing technological advances, more information can be collected and analyzed 
to develop new metrics to use to detect lymphedema. It is currently known that using 
volumetric measurements and their derivatives is a limiting factor of when lymphedema 
can be detected.55,109,110 This study developed and explored novel metrics as potential 
additions to volume that were created from a 3D scan of the arm. I was able to identify 
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some interesting metrics that have aided in a trained model’s ability to differentiate subtle 
differences between a healthy and a lymphedema case. 
This study showed that for this sample of patients, using volume difference alone 
resulted in poor sensitivity (33.3%), meaning many lymphedema patients were not 
classified as lymphedema patients based on this measurement. This low volume difference 
in arm volumes is representative of early stage lymphedema patients. This model was able 
to detect lymphedema patients at a much higher sensitivity (61%), and overall accuracy 
improved, albeit the sensitivity dropped approximately 5%. For the volume difference 
measurement to match the model’s sensitivity, the threshold would need to be reduced, 
which would also reduce accuracy and specificity. Specifically, to achieve a comparable 
sensitivity of 60%, the threshold needed for this data set would be around an 80 mL 
difference in volume, which would drop specificity below 40%.  
Similarly, the threshold for percent volume difference would need to be set at 3% 
for lymphedema detection, but sensitivity would drop to less than 33%. In comparison, this 
model performance was stronger with a specificity of 78% when the model sensitivity was 
60%. Further steps need to be taken to test the applicability of this model on patients 
immediately following cancer therapy, but prior to lymphedema detection, to assess if these 
classification algorithms would have a similar efficacy when compared to patients from 
this cohort, who were already diagnosed and are being actively treated for lymphedema. 
Simplifying the model to two classes did not improve the ability to detect lymphedema as 
shown in Figure 37.  
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The features that were used to train the patient 3-class model represented various 
local shapes of the arm. The average, median, and standard deviation of the perimeters and 
areas of each 1cm slice of the right and left arms describe how normal the distribution of 
the arm slices are. Additionally, the ratio of the perimeters of specific regions of along the 
length of the arm indicates that the relative size of the arm along the arm is different 
between lymphedema patients and non-lymphedema patients. Furthermore, the ratio of 
circularity of specific regions along the arm shows that swelling among lymphedema 
patients is different than the ratios on non-lymphedema patient arms. The mean, median, 
and lambda parameter to describe the inverse Gaussian distribution of vertex curvature 
continued to suggest that the arm shape differs when the arm is undergoing lymphedema 
onset. 
In conjunction with these local geometry-derived features, volume difference was 
a feature that passed through the feature filtering step. Interestingly, removing this single 
feature did not negatively impact the sensitivity of the trained model and even improved 
specificity, which indicated that volume difference as a feature had little weight in the 
trained model. Meanwhile, the average cross-sectional area of the arm as a feature to train 
the model could mean that the overall body mass of the patient is implicated in 
lymphedema detection.  
When the features were filtered for the training of the patient 2-class model, three 
features were identified, which were forearm angle, the standard deviation of the normal 
x-coordinates, and the arm length. None of these features were filtered in the patient 3-
class model and the lower performance of the patient 2-class model indicated that these 
features are less important for the detection of arm lymphedema.  
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The features that were filtered to train the arm model had many that overlapped 
with the features used to train the well-performing patient 3-class model except no 
difference between the right and left arms were taken. These features were descriptive of 
the shape of the arm like perimeter, area, circularity, and curvature but also included the 
vertices’ normals, which could potentially explain the poorer sensitivity rates that the arm 
classification model resulted in when testing on the testing set.  
While the arm classification model did not perform as well as the patient 3-class 
model, I explored the ability to classify individual arms, because patient classification is 
primarily beneficial for unilateral cases. Therefore, the subset of lymphedema patients who 
have bilateral manifestation of lymphedema are difficult to detect and diagnose. It is 
important to note that none of the patients in this cohort had bilateral lymphedema. There 
are currently no methods to classify bilateral lymphedema outside of the clinical centers 
with specialized lymphedema expertise. This study was the first to show some ability to 
detect lymphedema among arms, without requiring the paired arm to serve as a reference, 
but that model was not able to perform at the same level as the patient classification model 
as indicated by the sensitivity and specific.  
To appropriately determine the efficacy to detect and diagnose lymphedema with 
the Structure sensor, a rich dataset of long-term scans of patients from pre-treatment to 
periodic post-treatment for two to five years is needed. Such an ideal dataset does not exist 
as this scanning device is new on the market. Fortunately, I could collect scans of patients 
ranging in time post-treatment and in physical therapy progress. Patients with lymphedema 
are undergoing active therapy for their arm. Thus, the traditional volume difference is 
unable to identify the difference between a lymphedema arm and a healthy arm. 
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Through this aim, I explored the capacity of using the local geometries of an arm 
to identify lymphedema among female breast cancer survivors who are undergoing therapy 
as a result of the cancer treatment and/or for lymphedema. The Structure system was used 
to collect high resolution 3D scans of the patient arms and custom codes were developed 
to engineer features based on these scans. These features were used to train classification 
algorithms, and the most promising models were tested. Outcomes were evaluated to 
determine the performance of the models on the testing dataset. The features used to train 
the well-performing models show that these local features together can detect lymphedema 
and provide a foundation for features to further explore to determine if it has the capability 
to detect this disease earlier on in its progression. Rather than waiting for the arm to swell 
to a critical threshold, changes in these features that represent local geometries in well-
performing models could be an earlier indicator to watch for in the clinical setting.  
  
 107 
CHAPTER 5. CONCLUSION AND FUTURE DIRECTIONS 
5.1 Summary 
The implementation of an infrared sensor system as a substitute for lymphedema 
detection and monitoring is critical and a useful system for the lymphedema field. The 
systems used in this dissertation showed potential as a replacement for methods currently 
used in the clinics, tape measure circumferential measurements and the Perometer. These 
studies were one of the first that I am aware of where the system was implemented in clinics 
and performed by clinicians. I demonstrated that the Kinect system correlated and agreed 
well with the Perometer, which studies have shown to be a reliable tool limb measurement 
for volume. Because clinicians were successfully acquiring scans, it showed promise in its 
integration in the clinical space. Additionally, I determined a method of assessing change 
in volume for patients with a unilateral risk for lymphedema development.  
In the second aim, an updated iteration of the infrared sensor system was 
implemented. Studies have shown its accuracy and reliability compared to clinical 
measurement standards.111,112  I was able to focus on the potential applications of acquiring 
a true 3D scan of the arms. Specifically, I explored whether there are other metrics to use 
aside from volume to detect lymphedema. Rather than looking at the arm on global scale, 
I developed measurements that represent the local features of the arm that may manifest 
differently between healthy arms and lymphedema arms. I showed that using local features 
improves the ability to classify an arm as either healthy or lymphedematous compared to 
the gold standard of arm volume and its variant measurements like volume difference or 
percent difference in volume between the affected and unaffected arm. I believe that the 
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most exciting finding is to be able to identify arms as healthy or lymphedematous at an 
improved rate compared to the ability to detect whether a patient has lymphedema. This 
ability opens opportunities to detect bilateral lymphedema, which is an underserved 
demographic within an already underserved disease – lymphedema. While there is more 
work to determine the predictive value of these local measurements, it is a fundamental 
step towards lymphedema detection and with the right set of scans, the validity of the 
metrics determined in this dissertation can be assessed along with its predictive capabilities.  
5.2 Limitations 
There are several limitations in this work that can provide more validation regarding 
the implementation of infrared systems in the clinic and what metrics can be used in the 
detection and monitoring of lymphedema. First and foremost, given the time constraints 
and the lack of a dataset already available, the datasets collected for each study in this body 
of work were limited. The longitudinal dataset in aim 1B did not extend far enough post-
operatively. Therefore, the incidence rates of lymphedema in the study was much lower 
than what is found in the breast cancer survivor population. The datasets in aim 1A and in 
aim 2 did not have any longitudinal component. All patients were scanned at a single time 
point. While there was a healthy mix of lymphedema and non-lymphedema patients, the 
patients who had lymphedema were being actively treated for lymphedema and were at 
various stages of treatment.  
Additionally, in the first aim of the dissertation, the Kinect IR system did not output 
a true 3D scan of the limbs of interest. To explore local metrics would have been difficult 
as a limb was represented in two or three scans for the arms and legs respectively. While 
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the studies showed the Kinect IR system was a good alternative to current clinical tools for 
measuring volume, in order to compare the volume output on the Kinect IR system with 
other tools, an offset would be required. While calculating volume can still be done with 
good correlation and agreement with the clinical standards, the extent of its applications in 
this field was limited. Additionally, the Kinect’s commercial discontinuation would require 
an alternative infrared sensor for long-term implementation in the field.  
The largest limitation of this work is the sets of scans that could be gathered and 
their sample sizes. Because an existing dataset did not exist, all the samples were collected 
over the course of this dissertation and the rate of consent was a limiting factor. Especially 
in Aim 1B, this study had the lowest rate of attrition to the study. Due to the rate of breast 
cancer diagnosis at Grady Memorial Hospital combined with the consent rate, the medical 
team and I had a difficult time recruiting participants. I believe that the study logistical set 
up requiring patients to move to a dedicated room while waiting to check out of their 
appointment hindered the attrition rate. In future studies with the updated Structure system, 
the scans can occur in the patient’s room as a result of the portability of the system.  
While this iteration overcomes the portability issue and can output a true 3D 
representation of the limb, the system relatively expensive to the most common volumetric 
measurement tool, the tape measure. The price is not known, but the cost of materials would 
be approximately $1,300.87 I believe that despite its cost, the benefits and the time saved 
compared to the cheaper alternative, the tape measure, overcomes this financial obstacle.  
5.3 Future Considerations 
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Based on the results and feedback through the studies in this work, the 
implementation of the Structure system is feasible and would be an impactful next step. 
The Structure sensor is more portable than its predecessor, which would remove the 
requirement for a dedicated space or room for the scan. Therefore, the integration of this 
system into the clinical workflow could be more seamless. The impact of this integration 
is two-fold. First, studies gathering these scans would likely have a better attrition rate as 
the patient would not be required to move to a dedicated room. Secondly, clinicians are 
likely to start collecting these scans for patients who are at risk of developing lymphedema. 
Studies have outlined the implications of performing prospective surveillance with the 
early detection of the disease leading to better quality of life and the reduction of healthcare 
cost associated with managing lymphedema, which can be thousands of dollars. 44,105,113,114 
As clinics adopt this technology, more data can be collected on patients who are at 
risk for developing lymphedema and longitudinal scans could be collected. In addition to 
these scans, clinician diagnosis of lymphedema would ideally be collected in parallel. 
Therefore, these scans can be used to evaluate the metrics developed in this work on its 
potential to identify lymphedema onset earlier on in its progression. More specifically, it 
could be determined at which point the metrics from the scans would classify an arm as 
having developed lymphedema compared to when the clinician would make this 
determination. The ideal long-term implementation would be for this system to be used by 
at risk patients at home so prospective monitoring could be more easily performed.  
Overall, I believe that the impact of integrating infrared sensors can overcome some 
of the obstacles in the field of lymphedema and positively impact not only the lives of 
lymphedema patients but also those at risk for developing this disease.   
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APPENDIX A. MATLAB CODE 
A.1  Aim 2 Code 
A.1.1 TruncateArm.m 
%% TRUNCATEARM.M 
%% THIS FUNCTION TRUNCATES THE INITIAL SCAN .OBJ AT THE ARMPIT AND 
WRIST IN PREPARATION FOR THE FEATURE EXTRACTION 
%%Read in object 
ID = [{'1001'} {'1002'} {'1003'} {'1004'} {'1005'} {'1006'} {'1007'} 
{'1008'} {'1009'} {'1010'} {'1011'} {'1012'} {'1013'} {'1014'} {'1015'} 
{'1016'} {'1017'} {'1018'} {'1019'} {'1020'} {'1021'} {'1022'} {'1023'} 
{'1024'} {'1025'} {'1026'} {'1027'} {'1028'} {'1029'} {'1030'} {'1031'} 
{'1032'} {'1033'} {'1034'} {'1035'} {'1036'} {'1037'} {'1038'} {'1039'} 
{'1040'} {'1041'} {'1042'} {'1043'} {'1044'} {'1045'} {'1046'} {'1047'} 
{'1048'} {'1049'} {'1050'} {'1051'} {'1052'} {'1053'} {'1054'} {'1055'} 
{'1056'} {'1057'} {'1058'} {'1059'} {'1060'} {'1061'} {'1062'} {'1063'} 
{'1064'} {'1065'} {'1066'} {'1067'} {'1068'} {'1069'} {'1070'} {'1071'} 
{'1072'} {'1073'} {'1074'} {'1075'} {'1076'} {'1077'} {'1078'} {'1079'} 
{'1080'} {'1081'} {'1082'} {'1083'} {'1084'} {'1085'} {'1086'} {'1087'} 
{'1088'} {'1089'} {'1090'} {'1091'} {'1092'} {'1093'} {'1094'} {'1095'} 
{'1096'} {'1097'} {'1098'} {'1099'} {'1100'}]; 
  
path='C:\Users\ilu3\Dropbox (GaTech)\ME-DboxMgmt-Dixon-Brandon\Turning 
Point (H15203)\Structure scans (Summer 2018)\'; 
  
filetype='.obj'; 
side = 'right'; % or 'left'; 
  
WristXcoords=xlsread('C:\Users\ilu3\Dropbox (GaTech)\ME-DboxMgmt-Dixon-




    fn=[path ID{i} side filetype]; 
    obj=readObj(fn); 
    %obj x is length of arm, y is height, z is depth front to back 
     
    objSort = sortrows(obj.v,[1 -2 -3]);  
    %sort points in descending order based on x values then y then z 
    middleFinger=objSort(1,:); 
 
    %% remove trunk 
    % rotate the object 
    theta = 1*(pi/3+pi/2); % rotation angle 
    transmatrix = [cos(theta),sin(theta),0,0; - ... 
        sin(theta),cos(theta),0,0;0,0,1,0;0,0,0,1]; 
    transformation = affine3d(transmatrix); 
    ptCloud = pointCloud(obj.v,'Normal',obj.vn); 
    ptCloudOut = pctransform(ptCloud, transformation); 
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    data_all=ptCloudOut.Location; %pull data location points 
  
    [r c]=size(data_all); 
    ind=rot90(1:r,3); 
    data_all_origInd=[data_all, ind]; 
 
    %% Aligning x-coordinates 
    dataAlign=horzcat(round(data_all_origInd(:,1),2),... 
         data_all_origInd(:,2:end));  
         %move points to nearest cm in x direction 
    dataRotate4 = sortrows(dataAlign,[1 -2 -3]);  
    %sort points in descending order based on x values then y then z 
  
    origInd=dataRotate4(:,4); 
    dataRotate=dataRotate4(:,1:3); 
  
    armX=unique(dataRotate(:,1)); %find all unique x coordinates 
    armX=sort(armX,'ascend'); 
    armLowerBound = zeros(length(armX),3); 
  
    for n = 1:length(armX) 
        tempArm = find(dataRotate(:,1) == armX(n)); 
        armLowerBound(n,:) = dataRotate(tempArm(end),:); 
    end 
  
    [m,inde] = max(armLowerBound(:,2)); 
    armArmPit = armLowerBound(inde,:); 
    ArmandPit=[dataRotate;armArmPit]; 
    ArmandPitPtCloud = pointCloud(ArmandPit); 
  
    % Truncate  
    index = ArmandPitPtCloud.Location(1:end - ... 
         1,1)>=ArmandPitPtCloud.Location(end,1); 
    ArmRot=ArmandPitPtCloud.Location(index,:); 
    ArmRotPtCloud = pointCloud(ArmRot); 
    % Rotate the point cloud back 
    theta=-theta;  
    transmatrix = [cos(theta),sin(theta),0,0; - ... 
         sin(theta),cos(theta),0,0;0,0,1,0;0,0,0,1];  
         %update to rotate back 
    transformation = affine3d(transmatrix); 
    ArmPtCloudOut = pctransform(ArmRotPtCloud,transformation);  
    % performs operation on point cloud 
    PitCloudOut = pctransform(ArmandPitPtCloud,transformation); 
  
    rotatedArmPit=PitCloudOut.Location(end,:); 
    order=[index origInd]; 
    sortedorder=sortrows(order,2); 
    logic=logical(sortedorder(:,1)); 
  
    ArmPtCloudOut2=obj.v(logic,:); 
    ArmPtCloudNorm=obj.vn(logic,:); 
    ArmIndex2=ArmPtCloudOut2(:,1)<=(rotatedArmPit(1,1)-.01); 
  
    Arm2=ArmPtCloudOut2(ArmIndex2,:); 
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    ArmNorm2=ArmPtCloudNorm(ArmIndex2,:); 
    ArmPtCloudIL2 = pointCloud(Arm2,'Normal',ArmNorm2); 
    dataAlignXYZ=horzcat(round(ArmPtCloudIL2.Location(:,1),2), ... 
         ArmPtCloudIL2.Location(:,2:3));  
         %move points to nearest cm in x direction 
     
    %% Identify wrist manually 
    % [RWristX,~] = ginput(1); 
    % RWristX = round(RWristX,2); 
  
    %% Identify wrist with final x-coordinate from FinalWristX.m 
    if strcmp(side, 'left') == 1 
        WristX = WristXcoords(i); 
    elseif strcmp(side, 'right') == 1 
        WristX = WristXcoords(i+100); 
    end 
     
    %% Removing hand 
    objXYZ_Align = dataAlignXYZ; 
    objInd_Align = objXYZ_Align(:,1)>=WristX; 
    objXYZ_Align = objXYZ_Align(objInd_Align,:); %truncated the hand 
    objNorm_Align = ArmPtCloudIL2.Normal(objInd_Align,:);  
    %truncate normals associated with hand 
    object_Align = pointCloud(objXYZ_Align,'Normal',objNorm_Align);  
    %create pointCloud type with normals 
  
    % non aligned objXYZ 
    objXYZ_nonAlign_Index = ArmPtCloudIL2.Location(:,1)>=WristX; 
    objXYZ_nonAlign = ArmPtCloudIL2.Location(objXYZ_nonAlign_Index,:); 
    objNorm_nonAlign = ArmPtCloudIL2.Normal(objXYZ_nonAlign_Index,:);  
    object_nonAlign = ... 
         pointCloud(objXYZ_nonAlign,'Normal',objNorm_nonAlign); 
  
    % Save arm point cloud 
    vs = 'final'; 
  
    % Save .mat file  
    mat_fn = [path vs '\' ID{i} side vs '.mat']; 





%% THIS FUNCTION EXTRACTS FEATURES FROM TRUNCATED ARMS 
path = 'C:\Users\ilu3\Dropbox (GaTech)\ME-DboxMgmt-Dixon-
Brandon\Turning Point (H15203)\Structure scans (Summer 2018)\'; 
  
ID = [{'1001'} {'1002'} {'1003'} {'1004'} {'1005'} {'1006'} ... 
{'1007'} {'1008'} {'1009'} {'1010'} {'1011'} {'1012'} ... 
{'1013'} {'1014'} {'1015'} {'1016'} {'1017'} {'1018'} ... 
{'1019'} {'1020'} {'1021'} {'1022'} {'1023'} {'1024'} ... 
{'1025'} {'1026'} {'1027'} {'1028'} {'1029'} {'1030'} ... 
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{'1031'} {'1032'} {'1033'} {'1034'} {'1035'} {'1036'} ... 
{'1037'} {'1038'} {'1039'} {'1040'} {'1041'} {'1042'} ... 
{'1043'} {'1044'} {'1045'} {'1046'} {'1047'} {'1048'} ... 
{'1049'} {'1050'} {'1051'} {'1052'} {'1053'} {'1054'} ... 
{'1055'} {'1056'} {'1057'} {'1058'} {'1059'} {'1060'} ... 
{'1061'} {'1062'} {'1063'} {'1064'} {'1065'} {'1066'} ... 
{'1067'} {'1068'} {'1069'} {'1070'} {'1071'} {'1072'} ... 
{'1073'} {'1074'} {'1075'} {'1076'} {'1077'} {'1078'} ... 
{'1079'} {'1080'} {'1081'} {'1082'} {'1083'} {'1084'} ... 
{'1085'} {'1086'} {'1087'} {'1088'} {'1089'} {'1090'} ... 
{'1091'} {'1092'} {'1093'} {'1094'} {'1095'} {'1096'} ... 
{'1097'} {'1098'} {'1099'} {'1100'}]; 
len_IDnums = length(ID); 
  
vs = 'final'; 
filetype = '.mat'; 
  
%% load lymphedema outcomes 
outcomes_fn='C:\Users\ilu3\Dropbox (GaTech)\ME-DboxMgmt-Dixon-
Brandon\Turning Point (H15203)\Structure scans (Summer 
2018)\LEOutcomes.xlsx'; 
[num text raw] = xlsread(outcomes_fn); 
outcomes=raw; 
  
%% initialize the features output 
titles = [{'titles'}]; 
% % angles=[{'angles'}];              % forearm angle 
anglexy=[{'angle_xy'}];   
anglexz=[{'angle_xz'}];   
normals=[{'normals_XYZ'}];            % normals of arm points from scan 
normalx=[{'normalx'}]; 
normalx_avg = [{'normalx_avg'}]; 
normalx_med = [{'normalx_med'}]; 
normalx_std = [{'normalx_std'}]; 
normalx_range = [{'normalx_range'}]; 
normalx_kurt = [{'normalx_kurt'}]; 
normalx_skew = [{'normalx_skew'}]; 
normaly=[{'normaly'}]; 
normaly_avg = [{'normaly_avg'}]; 
normaly_med = [{'normaly_med'}]; 
normaly_std = [{'normaly_std'}]; 
normaly_range = [{'normaly_range'}]; 
normaly_kurt = [{'normaly_kurt'}]; 
normaly_skew = [{'normaly_skew'}]; 
normaly_alpha = [{'normaly_alpha'}]; 
normaly_beta = [{'normaly_beta'}]; 
normalz=[{'normalz'}]; 
normalz_avg = [{'normalz_avg'}]; 
normalz_med = [{'normalz_med'}]; 
normalz_std = [{'normalz_std'}]; 
normalz_range = [{'normalz_range'}]; 
normalz_kurt = [{'normalz_kurt'}]; 
normalz_skew = [{'normalz_skew'}]; 
normalz_alpha = [{'normalz_alpha'}]; 
normalz_beta = [{'normalz_beta'}]; 






circularities_range = [{'circularities_range'}]; 
circularities_kurt=[{'circularities_kurt'}]; 
circularities_skew=[{'circularities_skew'}]; 
perimeters=[{'perimeter'}];                 % cross section perimeters 
perimeters_ratio = [{'perimeter_ratio_shouldertowrist'}]; 
perimeters_avg = [{'perimeters_avg'}]; 
perimeters_med = [{'perimeters_med'}]; 
perimeters_std = [{'perimeters_std'}]; 
perimeters_range = [{'perimeters_range'}]; 
perimeters_kurt = [{'perimeters_kurt'}]; 
perimeters_skew = [{'perimeters_skew'}]; 
areas=[{'areas'}];                          % areas 
area_avg = [{'area_avg'}]; 
area_med = [{'area_med'}]; 
area_std = [{'area_std'}]; 
area_range = [{'area_range'}]; 
area_kurt = [{'area_kurt'}]; 
area_skew = [{'area_skew'}]; 
volumes_disc = [{'volumes_disc'}]; 
titles_circ = [{'circRatio_2to1'}, {'circRatio_3to1'}, ... 
    {'circRatio_4to1'}, {'circRatio_5to1'}, {'circRatio_6to1'}, ... 
    {'circRatio_7to1'}, {'circRatio_3to2'}, {'circRatio_4to2'}, ...  
    {'circRatio_5to2'}, {'circRatio_6to2'}, {'circRatio_7to2'}, ...  
    {'circRatio_4to3'}, {'circRatio_5to3'}, {'circRatio_6to3'}, ...  
    {'circRatio_7to3'}, {'circRatio_5to4'}, {'circRatio_6to4'}, ...  
    {'circRatio_7to4'}, {'circRatio_6to5'}, {'circRatio_7to5'}, ... 
    {'circRatio_7to6'}];  
circRatios = titles_circ'; 
titles_peri = [{'periRatio_2to1'}, {'periRatio_3to1'}, ...  
    {'periRatio_4to1'}, {'periRatio_5to1'}, {'periRatio_6to1'}, ...  
    {'periRatio_7to1'}, {'periRatio_3to2'}, {'periRatio_4to2'}, ... 
    {'periRatio_5to2'}, {'periRatio_6to2'}, {'periRatio_7to2'}, ... 
    {'periRatio_4to3'}, {'periRatio_5to3'}, {'periRatio_6to3'}, ... 
    {'periRatio_7to3'}, {'periRatio_5to4'}, {'periRatio_6to4'}, ... 
    {'periRatio_7to4'}, {'periRatio_6to5'}, {'periRatio_7to5'}, ... 
    {'periRatio_7to6'}]; 
periRatios = [titles_peri']; 
curvatures = [{'curvatures'}]; 
% curvatures based on findPointsNormal.m file 
curvature_avg = [{'curvature_avg'}]; 
curvature_med = [{'curvature_med'}]; 
curvature_std = [{'curvature_std'}]; 
curvature_range = [{'curvature_range'}]; 
curvature_kurt = [{'curvature_kurt'}]; 
curvature_skew = [{'curvature_skew'}]; 
curvature_mu = [{'curvature_mu'}]; 
curvature_lambda = [{'curvature_lambda'}]; 
  
%% extracting features 
for n=1:1:2 
    if n==1 
        side='left'; 
    else 
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        side='right'; 
    end 
     
    for m=1:1:len_IDnums 
        mat_fn = [path vs '\' ID{m} side vs filetype]; 
        load(mat_fn, 'objXYZ_Align', 'objXYZ_nonAlign', ... 
            'objNorm_Align','objNorm_nonAlign')  
         
        armID=[ID{m} side]; 
        titles=[titles {armID}]; 
  
        % FOREARM ANGLE; one-double output 
        [angle_xy, angle_xz]=forearm_angle(objXYZ_Align); 
        anglexy = [anglexy {angle_xy}]; 
        anglexz = [anglexz {angle_xz}]; 
        % NORMAL PER COORDINATE DIRECTION 
        normals=[normals {objNorm_nonAlign}]; %vector %v2 and v3 
        normalx=[normalx {objNorm_nonAlign(:,1)}]; %vector 
        normalx_avg=[normalx_avg {mean(objNorm_nonAlign(:,1))}]; 
%double 
        normalx_med=[normalx_med {median(objNorm_nonAlign(:,1))}]; 
%double 
        normalx_std=[normalx_std {std(objNorm_nonAlign(:,1))}]; 
%double 
        normalx_range=[normalx_range {range(objNorm_nonAlign(:,1))}]; 
%double 
        normalx_kurt=[normalx_kurt {kurtosis(objNorm_nonAlign(:,1))}]; 
%double 
        normalx_skew=[normalx_skew {skewness(objNorm_nonAlign(:,1))}]; 
%double 
        normaly=[normaly {objNorm_nonAlign(:,2)}]; %vector 
        normaly_avg = [normaly_avg {mean(objNorm_nonAlign(:,2))}]; 
%double 
        normaly_med=[normaly_med {median(objNorm_nonAlign(:,2))}]; 
%double 
        normaly_std=[normaly_std {std(objNorm_nonAlign(:,2))}]; 
%double 
        normaly_range=[normaly_range {range(objNorm_nonAlign(:,2))}]; 
%double 
        normaly_kurt=[normaly_kurt {kurtosis(objNorm_nonAlign(:,2))}]; 
%double 
        normaly_skew=[normaly_skew {skewness(objNorm_nonAlign(:,2))}]; 
%double 
        normaly_dist = fitdist((objNorm_nonAlign(:,2)+1)/2,'beta'); 
        normaly_alpha = [normaly_alpha {normaly_dist.a}]; 
        normaly_beta = [normaly_beta {normaly_dist.b}]; 
        normalz=[normalz {objNorm_nonAlign(:,3)}]; %vector 
        normalz_avg = [normalz_avg {mean(objNorm_nonAlign(:,3))}]; 
%double 
        normalz_med=[normalz_med {median(objNorm_nonAlign(:,3))}]; 
%double 
        normalz_std=[normalz_std {std(objNorm_nonAlign(:,3))}]; 
%double 
        normalz_range=[normalz_range {range(objNorm_nonAlign(:,3))}]; 
%double 
        normalz_kurt=[normalz_kurt {kurtosis(objNorm_nonAlign(:,3))}]; 
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%double 
        normalz_skew=[normalz_skew {skewness(objNorm_nonAlign(:,3))}]; 
%double 
        normalz_dist = fitdist((objNorm_nonAlign(:,3)+1)/2,'beta'); 
        normalz_alpha = [normalz_alpha {normalz_dist.a}]; 
        normalz_beta = [normalz_beta {normalz_dist.b}];         
 
        % CIRCULARITY; output is an array 
        [k, area, perimeter, circ, volume_disc]= ... 
circularity_v6(objXYZ_nonAlign); 
 
        volumes_disc = [volumes_disc {sum(volume_disc(1:end-1))}];  
         
        perimeters = [perimeters {(perimeter)}]; %vector 
        perimeters_avg = [perimeters_avg {mean(perimeter)}]; %double 
        perimeters_med = [perimeters_med {median(perimeter)}]; %double 
        perimeters_std = [perimeters_std {std(perimeter)}]; %double 
        perimeters_range = [perimeters_range {range(perimeter)}];  
%double 
perimeters_kurt = [perimeters_kurt {kurtosis(perimeter)}];  
%double 
        perimeters_skew = [perimeters_skew {skewness(perimeter)}];  
%double 
        circularities = [circularities {(circ)}]; %vector 
        circularities_avg = [circularities_avg {mean(circ)}]; %double 
        circularities_med = [circularities_med {median(circ)}]; %double 
        circularities_std = [circularities_std {std(circ)}]; %double 
        circularities_range = [circularities_range {range(circ)}];  
%double 
        circularities_kurt = [circularities_kurt {kurtosis(circ)}];  
%double 
        circularities_skew = [circularities_skew {skewness(circ)}];  
%double 
        areas = [areas {(area)}]; %vector 
        area_avg = [area_avg {mean(area)}]; %double 
        area_med = [area_med {median(area)}]; %double 
        area_std = [area_std {std(area)}]; %double 
        area_range = [area_range {range(area)}]; %double 
        area_kurt = [area_kurt {kurtosis(area)}]; %double 
        area_skew = [area_skew {skewness(area)}]; %double 
         
        % RATIOS; output is an array 
        [circularity_ratios, perimeter_ratios] = ... 
ratios(objXYZ_nonAlign); 
        % ratios are a horizonal array 
        circRatios = [circRatios num2cell(circularity_ratios)']; 
        periRatios = [periRatios num2cell(perimeter_ratios)']; 
                 
        % CURVATURE is per vertex (point in the 3D point cloud) 
        [normals, curvature] = findPointNormals(objXYZ_nonAlign); 
        curvatures = [curvatures {(curvature)}]; %vector 
        curvature_avg = [curvature_avg {mean(curvature)}]; %double 
        curvature_med = [curvature_med {median(curvature)}]; %double 
        curvature_std = [curvature_std {std(curvature)}]; %double 
        curvature_range = [curvature_range {range(curvature)}]; %double 
        curvature_kurt = [curvature_kurt {kurtosis(curvature)}];  
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%double 
        curvature_skew = [curvature_skew {skewness(curvature)}];  
%double 
        curvature_dist = fitdist(abs(curvature)+1e-16, ... 
'InverseGaussian'); %inversegaussiandistribution 
        curvature_mu = [curvature_mu {curvature_dist.mu}]; %double 
        curvature_lambda = [curvature_lambda {curvature_dist.lambda}]; 
%double 
    end 
end 
 
%% write to .xlsx 












circularities_skew;periRatios; circRatios;curvature_avg; ... 
curvature_med;curvature_std;curvature_range;curvature_kurt; ... 
curvature_skew;curvature_mu; curvature_lambda]; 
xlswrite([path '20190213_features_v1.xlsx'], data_single, ... 
'singleOutputs'); 






%% THIS FUNCTION TAKES IN THE OBJECT FILE AND OUTPUTS THE FOREARM ANGLE 
FROM THE XY PLANE AND FROM THE XZ PLANE. 
 
function [angle_y, angle_z]=forearm_angle(objXYZ) 
%objXYZ should be the arm cleaved at the shoulder and the wrist 
  
%compress image into x-y view by deleting the z-coordinate 
objXY=objXYZ(:,1:2); 
 
%find the min and max x-coordinates 
minX = min(objXY(:,1)); 
maxX = max(objXY(:,1)); 
 
%x-range of interest, first 33% of larm length 
forearmX = round((maxX-minX)/3,2)+minX; %add minX to find the 












%initiate cell array 
bin_XY = {}; 
bin_XZ = {};  
rows=0; 
  
%bin points by x coordinate 
for i=minX:0.01:forearmX 
    i=round(i,2); 
    ind_xy=[]; 
    ind_xz=[]; 
    ind_xy=objXY(:,1)==i; 
    ind_xz=objXZ(:,1)==i; 
    bin_xy=[]; 
    bin_xz=[]; 
    bin_xy = objXY(ind_xy,:);    
    bin_xz = objXZ(ind_xz,:); 
    [r,~]=size(bin_xy); 
    rows=rows+r; 
    bin_XY = [bin_XY {bin_xy}]; %concatonate cell array     
    bin_XZ = [bin_XZ {bin_xz}]; 
end 
  
%find the max y and min y at each x of the forearm  
for j=1:length(bin_XY) 
    %the top and bottom of arm (in y plane) 
    maxypt=max(bin_XY{j}(:,2)); 
    minypt=min(bin_XY{j}(:,2)); 
    maxypts=[maxypts maxypt]; 
    minypts=[minypts minypt]; 
    %the front and back of arm (in z plane) 
    maxzpt=max(bin_XZ{j}(:,2)); 
    minzpt=min(bin_XZ{j}(:,2)); 
    maxzpts=[maxzpts maxzpt]; 
    minzpts=[minzpts minzpt]; 
end  




%the top and bottom of arm (in y plane) 
p_maxy=polyfit(x_coord, maxypts,1); 
f_maxy=polyval(p_maxy,x_coord); %for plotting 
p_miny=polyfit(x_coord, minypts,1); 
f_miny=polyval(p_miny,x_coord); %for plotting 
%the front and back of arm (in z plane) 
p_maxz=polyfit(x_coord, maxzpts,1); 
f_maxz=polyval(p_maxz,x_coord); %for plotting 
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p_minz=polyfit(x_coord, minzpts,1); 
f_minz=polyval(p_minz,x_coord); %for plotting 
  
%angle of inclination (theta) 
%the top and bottom of arm (in y plane) 
angle_maxy=atand(p_maxy(1)); 
angle_miny=atand(p_miny(1)); 




%angle between two lines 
%the top and bottom of arm (in y plane) 
angle_y=abs(angle_maxy-angle_miny); %units: degrees 










%% THIS FUNCTION TAKES IN THE OBJECT FILE AND OUTPUTS THE CROSS-
SECTIONAL AREAS, CROSS-SECTIONAL PERIMETERS, CROSS-SECTIONAL 
CIRCULARITIES, VOLUME, AND ARM LENGTH. 
 
function [k,area,perimeter,circ,volume_disc,armLen]= ...  
circularity(objXYZ) 
    %objXYZ should be the arm cleaved at the shoulder and the wrist 
    minX = min(objXYZ(:,1)); 
    maxX = max(objXYZ(:,1)); 
    [r,~]=size(objXYZ); 
    objXYZ = sortrows(objXYZ, [1 2 3], {'ascend' 'ascend' 'ascend'}); 
    round = 0; 
    t=0.01; % in meters 
    rows=0; 
    round = round +1; 
    slice=[minX:t:maxX maxX]; 
    slice_num=length(slice)-1; 
    bin_X = {}; %initiate cell array 
    bin_size=zeros(1,slice_num); 
    for p=2:slice_num  
    %all except the last slice because it's not the same thickness 
        ind_i = []; 
        ind_i = objXYZ(:,1)<slice(p) & objXYZ(:,1)>=slice(p-1);  
        bin=[]; 
        bin = objXYZ(ind_i,:);    
        [r,~]=size(bin); 
        bin_size(p-1) = r; 
        rows=rows+r; 
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        bin_X = [bin_X {bin}]; %concatonate cell array     
    end 
        ind_i=objXYZ(:,1)>=slice(end-1); 
        bin=[]; 
        bin=objXYZ(ind_i,:); 
        [r,~]=size(bin); 
        rows = rows+r; 
        bin_size(end) = r; 
        bin_X = [bin_X {bin}]; 
    
    len=length(bin_X); 
    k = num2cell(zeros(1,len)); 
  
    area = zeros(1,len); 
    perimeter = zeros(1,len); 
    circ = zeros(1,len); 
    volume_step = zeros(1,len); 
  
    for j=1:length(bin_X) %length of the arm in cms  
        r=size(bin_X{1,j}); 
        if r(1)<10 | std(bin_X{1,j}(:,2))==0 | std(bin_X{1,j}(:,3))==0  
        else 
            % boundary 
            k{j}=boundary(bin_X{1,j}(:,2),bin_X{1,j}(:,3)); 
            y=bin_X{1,j}(:,2); 
            z=bin_X{1,j}(:,3); 
  
            % points from boundary function 
            tempk=k{j}; 
            yz_boundary = [y(tempk) z(tempk)];  
%k incl the first point as the last point also to complete 
circle 
  
            % calculating AREA 
            area(j) = polyarea(yz_boundary(:,1), yz_boundary(:,2)); 
  
% calculating VOLUME 
            volume_step(j) = area(j)*t; %m^2 * m so units is m^3  
 
            % calculate distance between points 
            peri = 0; 
            for p=2:length(yz_boundary) 
                dist=sqrt((yz_boundary(p,1)-yz_boundary((p-1),1))^2 ... 
 + (yz_boundary(p,2)-yz_boundary((p-1),2))^2); 
                peri = peri + dist; 
            end 
            perimeter(j) = peri; 
            circ(j) = (perimeter(j) .^ 2) ./ (4 * pi * area(j)); 
            if circ(j) > 2 
                k{j}=boundary(bin_X{1,j}(:,2),bin_X{1,j}(:,3),0.1); 
                y=bin_X{1,j}(:,2); 
                z=bin_X{1,j}(:,3); 
                tempk=k{j}; 
                yz_boundary = [y(tempk) z(tempk)]; 
                area(j) = polyarea(yz_boundary(:,1), yz_boundary(:,2)); 
                volume_step(j) = area(j)*.01; 
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                peri = 0; 
                for m=2:length(yz_boundary) 
                    dist = sqrt((yz_boundary(m,1)- ... 
yz_boundary((m-1),1))^2 + ... 
(yz_boundary(m,2)- ... 
yz_boundary((m-1),2))^2); 
                    peri = peri + dist; 
                end 
                perimeter(j) = peri; 
                circ(j) = (perimeter(j) .^ 2) ./ (4 * pi * area(j)); 
            else 
            end 
        end 
  % finishing calculation for VOLUME 
         t_last=maxX-slice(end-1); 
        volume_step(end) = area(end)*t_last; 
        volume_disc = sum(volume_step); 
        slices = slice_num; 
        bin_sizes = median(bin_size); 
        armLen = maxX - minX; 
    end 
     
    % for slices too small  
    if area(end)==0 
        area=area(1:end-1); 
        perimeter=perimeter(1:end-1); 
        circ=circ(1:end-1); 
        armLen = armLen - t; 
    else 
    end 
end 
 
A.2  Table of Local Geometry Features 
Table 12 Local Geometry Features 
Base features created 
Vector 
size per 
scan Feature Vector 





1x36  36 Regions 
Maximum Curvature 
(per region) 
1x36  36 Regions 
Mean Curvature 
(per region) 
1x36  36 Regions 
Gaussian Curvature 
(per region) 
1x36  36 Regions 




Volume 1x1 - 




Base features created 
Vector 
size per 



































































*  V represents the number of vertices in the arm scan 
** L represents the number of 1 cm slices in the arm scan (equals to the length of the arm 
in cm) 
A.3  Aim 2 Model Results 





















Table 14 Three-class patient classification training set outcomes 
 
1-1 1-2 1-3 2-1 2-2 2-3 3-1 3-2 3-3 Acc Sen Spec 
Fine Tree 8 0 5 0 2 3 6 3 23 0.66 0.556 0.719 
Medium Tree 8 0 5 0 2 3 6 3 23 0.66 0.556 0.719 
Coarse Tree 8 0 5 0 2 3 6 3 23 0.66 0.556 0.719 
Linear SVM 7 0 6 0 1 4 1 0 31 0.78 0.444 0.969 
Quad SVM 8 0 5 0 1 4 1 2 29 0.76 0.500 0.906 
Cubic SVM 7 0 6 0 1 4 5 4 23 0.62 0.444 0.719 
Fine Gaussian SVM 0 0 13 0 0 5 0 0 32 0.64 0.000 1.000 
Med Gaussian SVM 3 0 10 0 0 5 0 0 32 0.7 0.167 1.000 
Coarse Gauss SVM 1 0 12 0 0 5 0 0 32 0.66 0.056 1.000 
Fine KNN 9 0 4 0 1 4 7 4 21 0.62 0.556 0.656 
Medium KNN 8 0 5 0 0 5 4 0 28 0.72 0.444 0.875 
Coarse KNN 0 0 13 0 0 5 0 0 32 0.64 0.000 1.000 
Cosine KNN 11 0 2 0 0 5 6 0 26 0.74 0.611 0.813 
Cubic KNN 4 0 9 0 0 5 3 0 29 0.66 0.222 0.906 
Weighted KNN 9 0 4 0 0 5 3 0 29 0.76 0.500 0.906 
Boosted Trees 0 0 13 0 0 5 0 0 32 0.64 0.000 1.000 
Bagged Trees 7 0 6 0 1 4 2 1 29 0.74 0.444 0.906 
Subspace Disc 8 1 4 0 1 4 1 0 31 0.8 0.529 0.939 
Subspace KNN 3 0 10 0 1 4 8 1 23 0.54 0.222 0.719 
RUSBoosted Trees 11 0 2 0 4 1 6 11 15 0.6 0.833 0.469 
Linear Disc(Full) 9 1 3 0 2 3 3 3 26 0.74 0.647 0.788 
Quad Disc (Diag) 10 0 3 0 1 4 4 1 27 0.76 0.611 0.844 
* 1-1, 1-2, etc represent the [true-predicted] labels. 1 represents left lymphedema; 2 
represents right lymphedema; 3 represents non-lymphedema. To calculate sensitivity and 
specificity the following outcomes were denoted as True Positive = [1-1, 2-2], True 
Negative = [3-3], False Positive = [3-1, 3-2], False Negative = [1-2, 1-3, 2-1, 2-3] 
** Acc = accuracy, Sen = sensitivity, Spec = specificity 
 
Table 15 Three-class patient classification testing set outcomes 
 
1-1 1-2 1-3 2-1 2-2 2-3 3-1 3-2 3-3 Acc Sen Spec 
Medium Tree 5 0 8 1 2 2 8 1 23 0.6 0.412 0.697 
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Linear SVM 6 0 7 0 2 3 6 0 26 0.68 0.444 0.813 
Quad SVM 7 0 6 0 3 2 5 0 27 0.74 0.556 0.844 
Fine KNN 9 0 4 0 4 1 10 0 22 0.7 0.722 0.688 
Cosine KNN 9 0 4 0 0 5 10 0 22 0.62 0.500 0.688 
Weighted KNN 6 0 7 0 0 5 7 0 25 0.62 0.333 0.781 
Subspace Disc 7 0 6 0 3 2 7 1 24 0.68 0.556 0.750 
RUSBoosted Trees 8 1 4 0 3 2 9 6 17 0.56 0.647 0.515 
Linear Disc (Full) 5 4 4 1 3 1 7 2 23 0.62 0.615 0.622 
Quad Disc (Diag) 7 0 6 0 4 1 5 2 25 0.72 0.611 0.781 
* 1-1, 1-2, etc represent the [true-predicted] labels. 1 represents left lymphedema; 2 
represents right lymphedema; 3 represents non-lymphedema. To calculate sensitivity and 
specificity the following outcomes were denoted as True Positive = [1-1, 2-2], True 
Negative = [3-3], False Positive = [3-1, 3-2], False Negative = [1-2, 1-3, 2-1, 2-3] 
** Acc = accuracy, Sen = sensitivity, Spec = specificity 
 






Table 17 Two-class patient classification training set outcomes 
 
TN TP FN FP Accuracy Sensitivity Specificity 
Fine Tree 12 4 5 4 0.640 0.444 0.750 
Medium Tree 12 4 5 4 0.640 0.444 0.750 
Coarse Tree 12 4 5 4 0.640 0.444 0.750 
Logistic Regression 12 3 6 4 0.600 0.333 0.750 
Linear SVM 12 5 4 4 0.680 0.556 0.750 
Quad SVM 9 3 6 7 0.480 0.333 0.563 
Cubic SVM 6 4 5 10 0.400 0.444 0.375 
Fine Gaussian SVM 16 1 8 0 0.680 0.111 1.000 
Med Gaussian SVM 12 2 7 4 0.560 0.222 0.750 
Coarse Gaussian SVM 16 0 9 0 0.640 0.000 1.000 
Fine KNN 8 2 7 8 0.400 0.222 0.500 
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Medium KNN 13 2 7 3 0.600 0.222 0.813 
Coarse KNN 16 0 9 0 0.640 0.000 1.000 
Cosine KNN 13 1 8 3 0.560 0.111 0.813 
Cubic KNN 14 2 7 2 0.640 0.222 0.875 
Weighted KNN 10 4 5 6 0.560 0.444 0.625 
Boosted Trees 16 0 9 0 0.640 0.000 1.000 
Bagged Trees 9 5 4 7 0.560 0.556 0.563 
Subspace Discriminant 13 2 7 3 0.600 0.222 0.813 
Subspace KNN 11 2 7 5 0.520 0.222 0.688 
RUSBoosted Trees 11 4 5 5 0.600 0.444 0.688 
Linear Discriminant (Full) 12 4 5 4 0.640 0.444 0.750 
Quad Discriminant (Full) 11 4 5 5 0.600 0.444 0.688 
 
Table 18 Two-class patient classification testing set outcomes 
 
TN TP FN FP Accuracy Sensitivity Specificity 
Medium Tree 35 12 15 13 0.627 0.444 0.729 
Logistic Regression 30 8 19 18 0.507 0.296 0.625 
Linear SVM 33 12 15 15 0.600 0.444 0.688 
Bagged Trees 36 10 17 12 0.613 0.370 0.750 
RUSBoosted Trees 35 11 16 13 0.613 0.407 0.729 
Quad Discriminant (Full) 39 8 19 9 0.627 0.296 0.813 
 
























Table 20 Arm classification training set outcomes 
 
TN TP FN FP Accuracy Sensitivity Specificity 
Fine Tree 34 3 6 7 0.740 0.333 0.829 
Medium Tree 34 3 6 7 0.740 0.333 0.829 
Coarse Tree 34 3 6 7 0.740 0.333 0.829 
Logistic Regression 32 3 6 9 0.700 0.333 0.780 
Linear SVM 40 1 8 1 0.820 0.111 0.976 
Quad SVM 35 4 5 6 0.780 0.444 0.854 
Cubic SVM 35 2 7 6 0.740 0.222 0.854 
Fine Gaussian SVM 41 0 9 0 0.820 0.000 1.000 
Med Gaussian SVM 39 1 8 2 0.800 0.111 0.951 
Coarse Gaussian SVM 41 0 9 0 0.820 0.000 1.000 
Fine KNN 33 5 4 8 0.760 0.556 0.805 
Medium KNN 40 1 8 1 0.820 0.111 0.976 
Coarse KNN 41 0 9 0 0.820 0.000 1.000 
Cosine KNN 37 1 8 4 0.760 0.111 0.902 
Cubic KNN 41 0 9 0 0.820 0.000 1.000 
Weighted KNN 39 1 8 2 0.800 0.111 0.951 
Boosted Trees 41 0 9 0 0.820 0.000 1.000 
Bagged Trees 34 3 6 7 0.740 0.333 0.829 
Subspace Discriminant 39 3 6 2 0.840 0.333 0.951 
Subspace KNN 36 1 8 5 0.740 0.111 0.878 
RUSBoosted Trees 31 5 4 10 0.720 0.556 0.756 
Linear Discriminant (Full) 34 3 6 7 0.740 0.333 0.829 
Quad Discriminant (Diag) 36 4 5 5 0.800 0.444 0.878 
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Table 21 Arm classification testing set outcomes 
 
TN TP FN FP Accuracy Sensitivity Specificity 
Quad SVM 108 4 23 15 0.747 0.148 0.878 
Fine KNN 99 5 22 24 0.693 0.185 0.805 
RUSBoosted Trees 89 14 13 34 0.687 0.519 0.724 
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